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Abstract  
Telomeres at chromosome ends promote genome stability, survival, and proliferation in 
cells, and prevent degenerative diseases and cancer in humans.  Human telomeres are 
10-15 kilobases long and consist of about 1500 tandem TTAGGG repeats. Six telomeric 
proteins form a shelterin complex that protects the telomeres from being recognized as a 
chromosome break, thereby preventing inappropriate repair and chromosome fusions. 
Telomeric DNA sequences are vulnerable to ultraviolet light (UV)-induced damage. UV 
creates primarily two types of photoproducts within DNA: cyclobutane pyrimidine dimers 
(CPDs) and 6-4 photoproducts (6-4 PPs). Unrepaired photoproducts can stall or block 
DNA replication and transcription, or if tolerated and bypassed, can introduce mutations 
that cause genomic instability which can drive carcinogenesis. In genomic DNA, these 
potentially harmful cellular effects are avoided through a specialized nucleotide excision 
repair (NER) pathway that removes photoproducts and restores normal DNA.  
 
This dissertation investigated if photoproducts also form at chromosome ends and if they 
are repaired over time by NER. We exposed skin fibroblasts BJ-hTERT (NER proficient) 
and XP-A (NER deficient) to 10 J/m2 UVC which induces CPD and 6-4 PP lesions. We 
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then extracted genomic and telomeric DNA from these fibroblasts and measured the rate 
of lesion disappearance. Post UVC exposure, BJ-hTERT cells repaired all detectable 
telomeric 6-4 PPs by six hours and telomeric CPDs by two days. However, XP-A cells did 
not repair telomeric 6-4 PPs. We observed that unrepaired photoproducts inhibit telomere 
TRF1 protein binding to telomeric DNA in vitro, and that cellular UVC irradiation of NER 
deficient cells causes telomere aberrations. Our novel findings have uncovered the 
presence and importance of a major DNA repair pathway at telomeres and increase our 
understanding of how unrepaired bulky adducts at telomeres may impact telomere 
structure and function. Telomere maintenance is essential in protection against age-
related diseases and cancer in humans. The public health relevance of our study thus, 
relates to its potential usefulness in developing biomarkers of toxicology for aging and 
cancer. 
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1 INTRODUCTION 
1.1 TELOMERES: AN OVERVIEW 
1.1.1 Beginning of the end 
The word “telomere” first used in the 1940’s comes from combining two Greek roots –
“telos” meaning “end” and “meros” meaning “part or segment”, signifying terminal parts 
of linear chromosomes [1] . The first studies for telomeres began in the 1970s when 
Elizabeth Blackburn mapped Tetrahymena thermophila DNA and discovered a series of 
hexanucleotide repeat sequences at the terminal ends of the chromosomes. Blackburn 
and Jack Szostak discovered that telomeres are conserved protective structures when 
they found that inserting the isolated terminal sequences from Tetrahymena 
thermophila chromosomes into linearized yeast plasmid was able to prevent the linear 
DNA from being degraded in yeast [2].  
1.1.2 A solution to the end replication problem  
The discovery of the enzyme telomerase helped solve the then-existing dilemma of 
replication at the very ends of the chromosomes, defined as the “end-replication” 
problem [3]. Briefly, DNA replication is asymmetric in that the two daughter strands are 
synthesized differently because of the specific DNA polymerase 5’->3’ directional activity 
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that adds nucleotides at a free 3’ OH of an RNA primer that is bound to the 
template/parent DNA. Therefore, the leading strand is synthesized continuously from the 
primer in the 5’-> 3’ direction while the lagging strand (3’->5’) is synthesized 
discontinuously with several primers in the form of short Okazaki fragments. The primers 
are removed by an RNase enzyme and the Okazaki fragments are sealed with ligase 
[4]. The lagging strand synthesis presents a problem for replication at telomeres. The 
extreme ends of the chromosome after the removal of the final RNA primer cannot be 
replicated, causing shortening at the terminus with each round of cell division. The 
reverse transcriptase telomerase is able to resolve the problem in cells that express this 
enzyme. Telomerase elongates the parent 3’ strand further with its RNA template 
providing an extended template at the very end of the chromosome for synthesis of the 
lagging daughter strand by the DNA polymerase in a 5’->3’ direction [4].  
 
A search for an enzyme that lengthens telomeric DNA in Tetrahymena 
thermophila extracts revealed a novel activity of the “telomere terminal transferase” 
(telomerase), as shown by Blackburn and Greider [5]. Subsequently, telomerase was 
shown to have an RNA component (TERC) that in combination with its catalytic protein 
component (TERT: Telomerase Reverse Transcriptase) adds repeats de novo to the 3’ 
end of the chromosomes [6]. Blackburn, Greider and Szostak were collectively awarded 
the Nobel Prize in Medicine in 2009 for their exciting and groundbreaking work in the 
discovery of telomeres and telomerase. 
3 
1.1.3 Electron microscopy examination of telomeres and the discovery of 
telomere looping 
Telomeres in humans consist of 10-14 kilobases (kb) of double-stranded 5’ 
TTAGGG/5’CCCTAA tandem repeats, and terminate with a single stranded 3’ overhang 
that averages 100 nucleotides (see Fig. 1) [7]. In yet another startling discovery in the 
telomere field, Jack Griffith and colleagues in 1999 published evidence for a duplex lariat 
structure in isolated telomeres when viewed under an electron microscope, now 
commonly referred to as ‘t-loops’ [8] (see Fig. 1). The authors concluded that the 
telomere loops back upon itself with the 3’ G rich single stranded overhang invading the 
double stranded repeats and forming a smaller displacement loop or D loop (Fig. 1). The 
overall result is that the 3’ end is sequestered preventing the telomere from being 
recognized as a free end or a DNA double strand break (DSB).  Broken chromosome 
end structures generally invite DNA damage responses and excision or resection activity 
elsewhere in the genome [9]. 
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Figure 1 represents two scenarios for a chromosome end. The uncapped model is 
regarded to be telomeric double stranded DNA structure with a free 3’ overhang, and 
may be deficient in shelterin protein binding. The capped telomeric model shows part of 
the shelterin protein complex that directly binds to the DNA, namely TRF1, TRF2 and 
POT1, and shows the looped structure that sequesters the 3’ end. The three other 
shelterin proteins are RAP1, TPP1 and TIN2 and do not bind directly to the DNA (see 
section 1.1.4 for details). 
Figure 1: Telomere models 
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1.1.4 Current paradigm of telomeres with shelterin and associated proteins 
Telomeres are a complex of DNA and proteins. DNA repeats at telomeres co-exist with 
a 6-member protein complex named “shelterin” by Titia de Lange [7]. Shelterin proteins 
include: 
 Telomeric repeat binding factors 1 and 2 (TRF1 and TRF2) that bind to double 
stranded telomeric DNA.  
 Repressor activator site binding protein 1 (RAP1) that binds to and interacts with 
TRF2 directly. 
 Protection of telomeres 1 (POT1) that binds to single stranded telomeric DNA. 
 TIN2 POT1 organizing protein (TPP1) that binds to POT1 and TIN2. 
 TRF2 and TRF1 interacting nuclear protein 2 (TIN2) that bridges together TRF1, 
TRF2 and TPP1.  
Some non-telomeric accessory factors were also found to associate with the shelterin 
complex via pulldown experiments [9]. These include Ku 70/80, XPF-ERCC1, Apollo, 
and the Mre11 complex (Mre11/Rad50/Nbs1), which generally function in overall 
genomic DNA repair and maintenance.  
1.1.5 Role of shelterin in preserving telomere integrity 
The current paradigm for telomere structure in vitro is the capped shelterin-DNA model 
with the t-loops being formed and maintained partly by TRF2, which binds near the 3’ 
telomeric overhang [10]. TRF1 on the other hand is required for efficient replication and 
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to prevent fork stalling at telomeres [11]. Additionally, loss of TRF2 and other shelterin 
components can lead to uncapping and activation of inappropriate DNA damage 
response pathways at telomeres [12, 13]. Two of these DNA damage response 
pathways involve checkpoint signaling by ATM (ataxia telangiectasia mutated) kinase, 
which is activated by double strand breaks (DSBs), or ATR (ataxia telangiectasia and 
Rad3 related) kinase, which is activated by single strand breaks (SSBs) [13]. Importantly, 
when shelterin protein TRF1 was deleted in mice, the ATR kinase checkpoint was 
activated and the mice exhibited a fragile telomere phenotype [11]. Fragile telomeres are 
apparent as multiple telomeric signals or foci at a chromosome end [11]. NHEJ (non-
homologous end joining) and HR (homologous recombination) pathways that repair 
double strand breaks elsewhere in the genome are normally repressed at telomeres by 
shelterin proteins RAP1/TRF2 and POT1 respectively [14] [15, 16], to prevent end-to-
end chromosome fusions arising from illicit end joining and recombination [17]. 
1.1.6 Telomere length maintenance mechanisms and consequences of telomere 
dysfunction 
In germ line and stem cells, telomerase is required to maintain the telomeres. Loss of 
functional telomerase due to TERT or TERC mutations cause a variety of diseases 
including dyskeratosis congenita, pulmonary fibrosis, and aplastic anemia [18]. Failure 
to maintain telomere length causes gradual telomere shortening that along with oxidative 
stress and DNA damage responses are capable of inducing irreversible arrest in cell 
division (senescence) [19]. This is significant because there is some evidence that 
cellular senescence may contribute to cellular and organismal aging [20]. Average 
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telomere length has been widely studied as a possible biomarker for cellular health and 
aging, however, evidence indicates that a few critically short telomeres are sufficient to 
drive senescence and genome instability [21] [22]. Importantly, genomic instability 
arising from an accumulation of genomic damage and mutations is accepted as a 
hallmark of cancer and aging [23] [24]. 
 
Telomere maintenance is essential for continued cell proliferation.  Interestingly, cancer 
cells maintain their telomere lengths either by upregulating telomerase [25], or by using 
a recombination based alternative lengthening of telomeres (ALT) pathway.  Cells that 
use the ALT pathways have heterogenous telomere lengths and show a dysregulation 
of recombination at the telomeres [26].  
 
1.2 DNA DAMAGE AND REPAIR 
Cellular DNA is constantly subjected to various kinds of insults that are deleterious to the 
intact normal DNA structure. The sources for these insults can be classified as 
exogenous or endogenous. The endogenous sources including DNA hydrolysis, 
methylations, lipid peroxidation reactions and reactive oxygen species (ROS) introduce 
base damage in DNA [27]. Exogenous sources of insults come from the environment 
and include X-rays, ultraviolet (UV) light, chemicals such as polycyclic aromatic 
hydrocarbons, nitrates and even chemotherapeutics such as cisplatin (Pt) [28] (see Fig. 
2). For the sake of clarity, the term DNA ‘lesion’ commonly refers to a modified structure 
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of DNA arising from existing or new bonds within the DNA, while the term ‘adduct’ applies 
to covalent joining of a foreign, non-cellular compound to DNA. Lesions and adducts in 
damaged DNA are repaired by specialized DNA repair pathways. Some major pathways 
are highlighted in Fig. 2. 
 
Not all DNA repair pathways function similarly at telomeres as in the bulk genome. 
Importantly, double strand break repair is inhibited at normal telomeres by shelterin as 
mentioned previously (see section 1.1.5). In contrast, it is well established that base 
excision repair is functional at telomeres (see section 1.2.2). Whether NER functions at 
telomeres is controversial and is the central topic of investigation in this thesis (see 
section 1.3). 
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Possible DNA damage types, sources and associated repair pathways in genomic and 
telomeric DNA. NER: nucleotide excision repair, NHEJ/HR: non-homologous end 
joining/homologous recombination, ICLR: Inter strand cross link repair, MMR: mismatch 
repair, BER: base excision repair. 
 
Figure 2: DNA damage and repair pathways 
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1.2.1 Ultraviolet light (UV) as a toxic agent 
Ultraviolet (UV) light is a major toxicant for life forms on earth. Solar UV radiation consists 
of three types of UV light based on their wavelengths of electromagnetic irradiation: UVA 
(from 320-400 nm), UVB (from 295-320 nm), and UVC (100-295 nm) (see Fig. 3). Of 
these, only UVA and some of UVB fully penetrates the earth’s atmosphere. UV radiation 
from sun and tanning beds has been classified as a human carcinogen by the World 
Health Organization (WHO) and the Department of Health and Human Services [29]. 
The ozone barrier lining the earth’s atmosphere is critical for absorbing all of the UVC 
radiation and most of the UVB light, thus offering protection from the harmful effects of 
UV exposures which include skin cancers and cataracts in humans [30] [31].  95% of the 
UV light that penetrates the ozone layer is UVA light, while the remainder is UVB light. 
However, the risk for all types of UV exposure in causing adverse health effects is now 
increased in light of findings that human activities are causing a depletion of the ozone 
layer [32]. 
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Splitting of solar radiation into components. The size of the red dashed arrows represents 
amount of entry into earth’s atmosphere after ozone absorption. The broad red arrow 
indicates complete entry of visible and infra-red radiations into the earth’s atmosphere. 
  
Figure 3: Electromagnetic light spectrum 
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Because UV light has been a persistent toxicant since life originated, almost all life forms 
have evolved defense mechanisms to counteract UV damage.  UV germicidal lamps are 
popular tools to precisely monitor and deliver damage to study these defense 
mechanisms in the field of DNA repair. For example, both UVA and UVB induce oxidative 
DNA base damage in addition to UV photoproducts, while UVC specifically generates 
photoproducts with very little oxidative base damage [33]. UVC is also more efficient at 
causing DNA damage because while proteins inside cells absorb very little at 260 nm, 
the absorption peak of cellular DNA is maximal at 260 nm, which matches closely the 
wavelength of the UVC germicidal lamp wavelength (254 nm).  
1.2.2 Oxidative base damage in DNA 
As mentioned previously (see section 1.2), oxidative DNA damage can be produced in 
the microenvironment of the cell endogenously by the creation of reactive oxygen 
species (ROS). ROS creates various kinds of DNA lesions, most prominently 8-
oxoguanine (8-oxoG) [34]. Unrepaired 8-oxoguanine can potentially mispair with adenine 
eventually leading to G -> T transversions [35]. These mutagenic events are prevented 
by the efficient base excision repair (BER) pathway, which removes damaged bases in 
the global genome to restore normal DNA. In general, BER is a multi-step pathway that 
initiates with the action of specialized DNA glycosylase enzymes (such as Ogg1 and 
Nth1) that recognize damaged bases and cleave the N-glycosidic bond of the damaged 
base linked to the sugar-phosphate backbone, thereby creating an abasic or 
apurinic/apyrimidinic (AP) site. AP endonuclease enzyme further cuts the phospho-
diester bond on 5’ side of abasic site, thereby creating a single strand break (SSB), a 
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free 3’OH group and a 5’ dRP (deoxyribose phosphate). DNA polymerase beta has 
deoxyribophosphodiesterase (dRPase) activity in addition to polymerizing activity so it 
can process the 5’ dRP end to yield a 5’ phosphate (5’ P) and add nucleotides at the 3’ 
OH end [36]. Then, DNA ligase seals the SSB [37] to restore normal DNA. 
 
Various studies have examined the effect of oxidative damage on telomeres.  Guanine 
rich telomeres are highly susceptible to oxidative damage and chronic oxidative stress 
can accelerate telomeric shortening and the onset of cellular senescence as shown by 
Kurz, D.J. et al (2004) [38]. Oxidative damage (8-oxoGs) in telomeric DNA also disrupt 
binding of shelterin proteins TRF1 and TRF2 in vitro [39].  As mentioned previously, 
glycosylases such as Ogg1 and Nth1 remove oxidative lesions via BER pathway in vivo. 
Primary mouse embryonic fibroblasts (MEFs) were isolated from wild type (Ogg1+/+) and 
Ogg1 deficient (Ogg1-/-) mice and these isolated MEFs were either cultured in 20% 
oxygen or paraquat that induced oxidative stress, or normal 3% oxygen conditions to 
lessen oxidative stress [40]. The authors observed that high oxidative stress in Ogg1-/- 
primary MEFs enhanced telomeric DNA strand breaks and led to telomere strand losses, 
which was associated with an accumulation of oxidative lesions such as 2,6-diamino-
4-hydroxy-5-formamidopyrimidine (FapyG) and 8-oxoGs normally removed by 
Ogg1 glycosylase [40]. A similar study was performed to test effect of Nth1 
(Endonuclease III-like protein 1) deficiency on mice telomeres [41]. MEFs were isolated 
from wild type (Nth1+/+) and knockout (Nth1-/-) mice and treated with aphidicolin that 
induce replication stress and enhance telomere fragility [41]. The authors recorded a 
higher incidence of fragile telomeres and higher telomere sister chromatid exchanges in 
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primary MEFs isolated from Nth1 deficient mice compared to wild type control mice. The 
authors associated this increase in telomere fragility and T-SCEs with Nth1 deficiency 
and suggested that an accumulation of telomeric Endonuclease III-sensitive DNA lesions 
due to absence of Nth1 could be responsible for the observed telomere defects [41]. 
Thus, in both these studies, the removal of oxidative lesions by Ogg1 and Nth1 
glycosylases via BER was shown to be important for maintaining telomeric integrity [40, 
41]. In another related study, human AP endonuclease 1 (Ape1) was shown to have a 
key role in telomere maintenance [42]. Ape1 protein recognizes and processes 
apurinic/apyrimidinic (AP) sites in the base excision repair pathway of DNA. The authors 
performed telomere FISH assays in Ape1 depleted U2OS, BJ-hTERT and primary 
fibroblasts IMR90 cells and observed telomere end-to-end fusions and telomere losses 
[42]. This led to the conclusion that Ape1 deficiency was associated with telomere 
dysfunction [42]. Related to this, Ape1 depletion in U2OS and BJ-hTERT cells was also 
found to be associated with reduced TRF2 at telomeres which in turn was associated 
with activation of DNA damage responses at telomeres [42]. Thus, oxidative damage 
and repair have been well characterized at telomeres. 
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1.2.3 UV-induced bulky lesions and repair in genomic DNA 
The majority of UV-induced DNA damage is in the form of cyclobutane pyrimidine dimers 
(CPDs) [43] [44]. CPDs are formed when adjacent pyrimidines (thymines/cytosines) link 
together covalently via formation of a four member ring structure resulting from saturation 
of pyrimidine 5, 6 carbon double bonds (see Fig. 4). Various stereo isoforms of CPDs 
are possible such as cis-syn, cis-anti, trans-syn or trans-anti. Double stranded B DNA 
forms mostly the cis-syn CPD when exposed to UV light, while single stranded DNA can 
form trans-syn dimers which generates a greater distortion in the helical structure [44]. 
CPDs are formed in a sequence context. Thymine-thymine (T<>T) CPDs are the most 
frequently formed, compared to cytosine-cytosine (C<>C) CPDs which are the least 
frequently formed. Thus, the overall frequency of CPD formation in a sequence context 
was observed to be T<>T: C<>T: T<>C: C<>C at a ratio of 68:13:16:3 [43, 45]. 
Pyrimidine (6-4) pyrimidone photoproducts (6-4 PPs) are formed when two pyrimidines 
link together covalently across the 4, 6 carbon double bonds. 6-4 PPs introduce a much 
more prominent distortion in the double helical structure of DNA than CPDs [46] but like 
CPDs they also form in a sequence context.  6-4 PPs form most frequently at TC and 
CC sites, and less frequently at TT and CT sites [47, 48]. In human telomeres, which 
consist of the sequence 5’ TTAGGG/5’ CCCTAA, CPDs and 6-4 PPs can form at the 
TTs, CCs, and CTs residues.  Irradiation of an existing 6-4 PP lesion with 313-325 nm 
light can form Dewar isomer-derivatives considered to be a type of secondary damage 
[37]. The ratio of CPD to 6-4 PP formation upon UVC exposure of B-DNA was found to 
be 3:1 [49], while the ratio upon UVB exposure was found to be 8:1 [50].  
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CPDs and 6-4 PPs in some vertebrates (except mammals), bacteria and plants can be 
repaired via photoreactivation or photoreversal by specific chromophore containing 
enzymes called CPD or 6-4 PP photolyases [51]. Mammalian cells however lack 
photoreversing enzymes and repair the bulky photoproducts via the nucleotide excision 
repair (NER) pathway. Unrepaired UV damage in DNA can lead to irreversible nucleotide 
sequence changes in the genome, termed as mutations.  
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Left: Skeletal formula of thymine dimer showing joining across 5 and 6 double bonds. 
Right: Skeletal formula of pyrimidine (6-4) pyrimidine photoproduct showing joining 
across 4 and 6 bonds. 
 
Figure 4: Structures of ultraviolet light induced CPDs and 6-4 PPs 
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1.2.4 UV mutagenesis and photoproduct removal  
UV mutagenesis in DNA can be caused by multiple factors and mechanisms. Cytosine 
in DNA is unstable compared to other bases and can undergo hydrolytic deamination 
irreversibly to form uracil. Also, if cytosine is a part of a CPD, this increases the frequency 
of cytosine deamination to uracil [52]. At dipyrimidine sites, deamination of CC’s can thus 
create uracil (UU) containing CPDs. Moreover, methylated cytosines deaminate at a 
greater rate than normal cytosines, which lead to conversion to thymine [53]. Also, UVB 
as part of sunlight induces CPDs preferentially at 5 methylcytosine dipyrimidine sites 
[54]. 
 
CPDs in general serve as impediments to replicative polymerases, which can cause 
stalling at replication forks, potentially leading to fork collapse into a double strand break 
and consequent cell death [55]. These events can be prevented by a DNA damage 
bypass/tolerance mechanism in cells known as translesion DNA synthesis. Specialized 
translesion polymerases are able to prevent fork collapse or can re-start stalled 
replication forks in an ‘error-free’ or ‘error prone’ way, depending on the type of lesion 
and the type of translesion polymerase recruited to the lesion [56]. Translesion 
polymerase eta (Pol η) can synthesize accurately across TT CPDs including those 
formed due to deamination of methyl cytosines at dipyrimidine CPD sites. The bypass is 
error-free in incorporating correctly adenines across thymines. However, it is deleterious 
to the cell because it can potentially cause C->T or CC->TT mutations, which are 
signature UV mutations, if bypass occurs at methylated cytosine CPDs that could 
19 
deaminate to TT CPDs [57]. Also, although Pol η is efficient at bypassing CPDs, it is 
ineffective at the bypass of 6-4 PPs.  
 
Most of the UV-induced mutations are single base pair substitutions, that are 
concentrated at hotspots (non-random) and directed at the 3’ residues of pyrimidine 
dinucleotides [58] [37, 59]. UVA and UVB generate a diverse spectrum of mutations in 
DNA. UVA generates photosensitizing reactions that produce oxidized bases that lead 
to G-> T transversions while UVB produces bulky lesions such as CPDs and 6-4 PPs 
that create single (C->T) or tandem (CC->TT) transition mutations [33]. However, recent 
studies point to UVA induced CPDs in whole human skin as the predominant lesions, as 
opposed to 8-oxo-7,8-dihydroguanine (8-oxoG), and report no formation of 6-4 PPs 
at thymine sites [60]. 
 
As mentioned earlier, removal of photoproducts from genomic DNA is critical because 
they impede progression of the normal replicative DNA polymerases during DNA 
replication. For example, CPDs introduce a helical distortion by bending the overall 
helical axis by 30° toward the major groove [61, 62]. CPDs are particularly deleterious 
due to poor recognition by the global genome excision repair pathway and therefore, 
exhibit longer persistence in the DNA compared to 6-4 PPs [63]. In normal cells 12 hours 
after UV exposure, about 50% of CPDs are removed from mammalian DNA [64-66]. On 
the other hand, 6-4 PPs which are more helix distorting than CPDs are recognized and 
removed at a much faster rate than CPDs. By 6 hours post UV exposure most of the 6-
4 PPs are repaired in genomic DNA [49].  
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1.2.5 Types of Nucleotide Excision Repair (NER) 
CPDs and 6-4 PPs are repaired in mammalian cells via the nucleotide excision repair 
(NER) pathway. Areas of genome that are transcriptionally silent or non-transcribing at 
any given time, are repaired by the Global Genome Repair (GGR) pathway while lesions 
within actively transcribing regions are repaired by the Transcription-Coupled Repair 
(TCR) pathway (reviewed in Friedberg et al [37] (see Fig. 5). The distinction between the 
two pathways lies in the initial steps of lesion recognition.  The translocating RNA 
polymerase II (RNA pol II) in TCR senses a replication block in the template strand and 
stalls, following which it recruits TCR specific proteins Cockayne syndrome A (CSA) and 
Cockayne syndrome B (CSB). CSB strongly binds to RNA pol II at the site of stalling 
[67]. CSA is a substrate recognition factor that recruits ubiquitin proteases, nucleosome 
binding as well as scaffolding proteins, and is responsible for the degradation of CSB 
post damage recognition [68].  For GGR, the helix distortion is recognized by the main 
damage sensor protein complex XPC-H23RB, which binds to the lesion. Ultraviolet DNA 
damage binding protein (UV-DDB) complex facilitates recognition of a photoproduct 
lesion by flipping it out, which further kinks the DNA to create a ssDNA region for XPC 
binding [69]. 
 
After the lesion recognition step, the two NER pathways unite into a similar sequence of 
events. The transcription initiation factor complex TFIIH is recruited to the lesion site in 
association with its helicase subunits XPD and XPB which melt the duplex DNA around 
the lesion to form a ‘bubble’ structure [70, 71], followed by verification of the lesion in the 
damaged strand [72]. Next, a preincision complex is formed by recruiting proteins XPG, 
21 
RPA and XPA.  XPG endonuclease is recruited by interaction with TFIIH [73].  
Replication protein A (RPA) coats the undamaged single stranded DNA resulting from 
the open bubble structure [74]. XPA protein also binds to the damaged DNA strand and 
then recruits the heterodimer complex XPF-ERCC1 [75]. XPG and XPF-ERCC1 are 
structure-specific endonucleases that make dual incisions on the 3’ and 5’ ends of the 
lesion containing strand respectively, leading to the release of a 24-32 nucleotide single 
stranded piece of DNA [76]. Replication factor C (RFC) and proliferating cell nuclear 
antigen (PCNA) complex together facilitate loading of DNA polymerase to synthesize the 
new strand [77]. The Ligase III-XRCC1 complex carries out the final ligation step to seal 
the nick in the strand [78]. 
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A replication/transcription blocking lesion may be formed in either a transcribing (left) or 
non-transcribing (right) region of genome, which determines initial recognition by two 
distinct NER pathways: transcription coupled repair (TCR- left) or global genome repair 
(GGR- right). Lesion recognition is achieved by a stalled RNA polymerase II along with 
recruitment of Cockayne syndrome A and B proteins (CSA and CSB) for TCR and by 
XPC-RAD23B, UV-DDB complex proteins for GGR. The remaining steps of the pathway 
are shared by TCR and GGR resulting in recruitment of NER proteins and TFIIH 
transcription complex, which ultimately results in removal of a 24-32 nucleotide damaged 
fragment containing the lesion. The ensuing gap is filled by DNA polymerase and the 
nick is sealed by the action of ligase.  
 
Figure 5: Sequence of events in eukaryotic nucleotide excision repair (NER) 
pathway 
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1.2.6 The case of no repair: XP and complications arising from lack of NER 
Defective or absent NER pathways cause xeroderma pigmentosum (XP), a rare 
autosomal recessive genetic disease that encompasses 8 disease subtypes which differ 
in severity depending on the affected complementation protein in the pathway. The first 
seven are classified as XP-A through XP-G and are caused by mutations in genes that 
encode or NER proteins. The eighth subtype (XP-V) is caused by a mutation in the gene 
that encodes Pol η (translesion polymerase) resulting in defective translesion synthesis 
past UV-induced lesions [79]. 
 
The absence of NER pathways causes diverse and severe adverse health effects. 
Primarily, NER deficiency causes a >10,000-fold increase in skin cancer risk, 
presumably due to an accumulation of mutations resulting from CPD and 6-4 PP 
photoproducts [80]. The frequency of XP is about one per one million people in the United 
States and Europe. XP patients sometimes have an average onset age of <10 years for 
the first skin cancer [80, 81]. XP patients are characterized by having greater skin sun 
sensitivity than normal people.  Exposed areas of the skin, tongue, eyes and extremities 
are highly susceptible to sunburns and melanomas.  Patients suffering from the more 
severe form of XP can also exhibit neurological abnormalities including developmental 
delay, loss in sensorineural hearing, the ability to walk, and neuronal atrophy and 
degeneration, caused by defects in XPA, XPB, XPD or XPG proteins [79]. Importantly, 
XPV patients lack translesion synthesis polymerase Pol η as opposed to lacking an NER 
pathway protein. These patients exhibit sun sensitivity and skin cancers similar to other 
XP patients, but possess a fully functional NER pathway [57]. 
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While XP is primarily due to defects in any of the complementation proteins mentioned 
above, other related diseases are CS (Cockayne syndrome), TTD (Trichothiodystrophy) 
and a rarer combined XP/CS disorder. CS is an autosomal recessive disease thought to 
primarily arise from lack of transcription coupled repair (TCR). TCR occurs due to 
mutations in the genes encoding the DNA translocase Cockayne syndrome group B 
protein (CSB) or the ubiquitin ligase associated Cockyane syndrome group A (CSA) 
protein [82]. Thus, the CS patients suffer from transcription related problems in DNA and 
possess a dysfunctional TCR pathway but an intact cellular GGR pathway. Patients with 
CS suffer from severe growth arrest, premature aging like symptoms and developmental 
abnormalities. They have accelerated demyelination of neurons in the brain, 
microcephaly, sensorineural deafness and overall very low life expectancy (12 years) 
[83]. TTD is caused by very specific mutations in TTDA, XPB or XPD proteins which are 
part of the basal transcription complex TFIIH [79]. Patients suffering from these diseases 
exhibit severe phenotypes due to disruption in the basal transcriptional machinery and 
show features of CS phenotypes in varying degrees along with brittle hair and nails 
(reviewed in [81]). 
 
1.2.7 UV damage and NER at telomeres 
Knowledge about UV-induced damage and repair at telomeres has been limited to 
findings by just two previous studies done in the field. This could be because 1) 
telomeres are less than 0.02% of the bulk genome [84] and hence, there are limited 
techniques that can investigate telomeres with specificity and sensitivity and 2) 
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telomeres were only recently discovered to be actively transcribing regions of the 
genome raising the potential for TCR existence at telomeres [85]. A study by Rochette 
and Brash in 2010 first concluded that UV-induced CPDs are not removed from 
telomeres despite showing evidence for hypersensitivity of telomeres to CPD formation 
[86]. The implication was that telomeres tolerate lesions perhaps through translesion 
synthesis, which enables bypass of UV photoproducts in genomic DNA. However, an 
earlier study by Kruk et al. in 1995 measured rates of telomeric CPD repair along with 
repair rates in transcribing and non-transcribing genes, and concluded that the telomeric 
CPD repair rate resembles that of non-transcribed genes [87]. Slower or no repair of 
telomeric CPDs, compared to CPD repair in the bulk genome, has the potential to cause 
replication and transcription blocks in telomeres, which can further lead to genomic 
instability. 
 
Effect of chronic UVB exposure on telomeres in mice was recently examined in a study 
that used an XP mouse model. XP mouse models generated by complete knockout of 
NER proteins are useful in understanding human XP diseases. XPC as mentioned 
previously, is a global genome repair (GGR) pathway protein whose deficiency leads to 
a defective NER pathway [88]. When the dorsal skin of XPC knockout mice was exposed 
to a chronic dose of 1.8 kJ/m2 UVB and examined, the authors of the study discovered 
that chronic UVB increased telomere shortening and introduced greater fragility at 
telomeres compared to wild type mice [89]. This study was the first to examine and report 
deleterious effects of UV on telomeres in animal tissues, but could not conclusively 
answer if NER protects telomeres from UV-induced damage. This is because UVB 
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exposures were utilized which also induce oxidative damage, and XPC has also been 
implicated in base excision repair for removal of oxidative damage [90, 91]. 
 
Some studies have also examined NER protein XPF-ERCC1 behavior in presence of 
shelterin complex protein TRF2. In these studies, NER incision factor XPF-ERCC1 was 
found to localize to telomeres as well as to co-purify with shelterin protein TRF2 in 
pulldown experiments [92, 93]. Also, XPF-ERCC1 protects telomeres by repressing 
telomeric recombination events, but in the absence of TRF2 it cleaves the 3’ overhang 
at telomeres thereby facilitating deleterious chromosome end-to-end fusions [92]. 
Preliminary data from our lab (see appendix) indicates that TRF2 can modulate activity 
of XPF-ERCC1 on a non-telomeric substrate.  
1.3 STATEMENT OF THE PROBLEM AND HYPOTHESIS 
Telomeric DNA is particularly susceptible to genotoxic stress because of 1) a high 
frequency of tandem pyrimidines that are hotspots for bulky photoproduct damage and 
guanines that are hotspots for oxidative damage [86] and 2) suppression of DNA double 
strand break repair pathways at telomeres [9, 14, 94]. UV is a ubiquitous source of DNA 
damage, is a complete carcinogen and has been used extensively to study B-DNA 
damage and repair [37]. Helix distorting DNA lesions such as UV-induced CPDs have 
the potential to cause cell death or mutagenesis by interfering with DNA transcription 
and replication. Organisms have evolved a transcription coupled NER pathway to more 
rapidly remove bulky lesions from transcriptionally active DNA [95]. Telomeres were very 
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recently shown to be actively transcribed into non-coding RNAs called telomeric repeat 
containing RNA (TERRA), which aid in telomere maintenance and prevent premature 
cellular senescence [96]. It is thus, important to investigate whether damage at 
dynamically transcribing telomeres is repaired, accumulates or is tolerated.  
 
While oxidative damage and the base excision repair pathway are well characterized at 
telomeres [38, 40] (also summarized in 1.3), the status of UV-induced bulky damage and 
repair at telomeres is not clear. Studies investigating NER function at telomeres or 
interactions of NER proteins with telomeric proteins are limited to two NER proteins; XPC 
and XPF-ERCC1, as described in section 1.2.7. Stout and Blasco recently showed that 
UVB exposure of mice lacking NER protein XPC induced an increase in critically short 
telomeres, compared to exposed wild type mice. The authors also suggested that 
telomere lengths in double knockout mice (having a combined XPC and telomerase 
deficiency) were increased after UVB exposure perhaps due to activation of the 
alternative lengthening of telomeres pathway (ALT, described briefly in section 1.1.6) 
[89]. Thus, XPC and telomerase work together to maintain telomeres in mice upon UV 
exposure. Moreover, despite evidence for interactions of NER protein XPF-ERCC1 and 
shelterin protein TRF2 via co-immunoprecipitation experiments [92], it is unknown if 
XPF-ERCC1 and TRF2 directly interact to modulate each other’s activity. 
 
Two studies that examined UV-induced photoproduct removal at telomeres reported 
contrasting results. Kruk et al (1995) reported that the rate of CPD repair at telomeres 
after UV exposure was similar to that observed for non-transcribing genes [87]. Rochette 
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and Brash reported that telomeres are hypersensitive to UV-induced CPD formation, but 
refractory to CPD removal [86]. Additionally, these previous studies did not directly 
measure the potential role of NER proteins in telomeric CPD removal and used semi-
quantitative methods to measure CPDs.  
 
The objective of this research was to investigate the presence of a potential NER 
pathway operating at telomeres. My central hypothesis was that telomeres exhibit slower 
NER of UV-induced DNA damage, as compared to genomic DNA, and that UV 
photoproducts can affect shelterin integrity at telomeres. In order to address this 
hypothesis, the specific aims were 1) to determine what effect UV-induced 
photoproducts have on shelterin protein binding to telomeric DNA and 2) to measure 
repair kinetics of UVC-induced photoproducts at telomeres. For my first aim, I performed 
gel shift assays to test the effect of a CPD on binding of shelterin protein TRF1 to 
telomeric DNA. For my second aim, I developed, standardized and validated a novel and 
sensitive immuno-DNA spot blot based assay for telomeric lesion quantification. 
Knowledge about the formation and removal of photoproducts in telomeric DNA will 
advance our understanding of bulky lesion repair across the mammalian genome. 
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1.4 STATEMENT OF PUBLIC HEALTH SIGNIFICANCE 
Nucleotide excision repair (NER) is the principal DNA repair pathway that removes a 
multitude of distinct types of bulky DNA lesions caused by major chemical mutagens. 
NER removes environmentally induced DNA insults such as benzo[a]pyrene adducts 
[97], polycyclic aromatic hydrocarbon adducts [98], 2-acetylaminoflourene adducts (dG-
C8-AAF) [99], aristolactam (AL-DNA) adducts [100], aflatoxin B1 formamidopyrimidine 
adducts [101], chromium-DNA adducts [102] as well as chemotherapeutically induced 
cisplatin-DNA adducts [103]. However, the most well- studied and established bulky 
lesions repaired by NER remain the evolutionarily significant ultraviolet (UV) light 
induced cyclobutane pyrimidine dimers and 6-4 photoproducts. 
 
Telomeric sequence is especially susceptible to UV photoproduct formation due to the 
presence of adjacent pyrimidines within each telomeric repeat. A recent study measured 
telomere lengths using quantitative fluorescence in situ hybridization in sun exposed and 
sun protected skin areas and found that basal cell telomeres were shorter in sun exposed 
epidermal areas with or without actinic keratosis as compared to telomeres in sun 
protected epidermal areas [104]. Unrepaired genomic DNA photoproducts serve as 
replication blocks that can further lead to mutations and genomic instability, which is a 
hallmark of cancer. 
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Our study aims to define clearly the picture of UV lesion formation and abolition at 
telomeres and to investigate in depth whether NER is truly functional in protecting 
telomeres from the adverse effects of these lesions. We foresee two distinct ways in 
which this study will contribute to improving human health. First, knowledge about a 
functional telomeric NER pathway will help elucidate novel strategies to preserve or 
upregulate NER protection of normal telomeres in the face of constant environmental 
stressors. Conversely, NER inhibition or modulation in cancer cells, combined with drug 
therapy can greatly sensitize tumors to killing [105, 106]. Second, knowledge from our 
study will inform about telomeric damage endpoints such as impaired shelterin binding 
to telomeres and telomeric dysfunction (telomere loss, fusions etc.) due to 
photoproducts. Telomere dysfunction can drive carcinogenesis in cells that lack tumor 
suppression and evade senescence. Unrepaired UV damage can drive senescence 
causing accelerated photo-aging [107]. Telomere maintenance is thus, essential in 
protection against age-related diseases and cancer in humans. Finally, telomeric DNA 
damage and toxicity is an emerging field and our novel techniques will allow future 
investigations into all the varied bulky adducts (outlined above) that could form at 
telomeres.  
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2 TELOMERES ARE PROFICIENT IN REMOVAL OF UV INDUCED 
PHOTOPRODUCTS VIA NUCLEOTIDE EXCISION REPAIR 
2.1 ABSTRACT 
UV irradiation induces photoproducts in the genome that if left unrepaired can interfere 
with DNA replication and transcription, and ultimately lead to mutations or chromosome 
breaks. Telomeric TTAGGG/CCCTAA repeats at chromosome ends are enriched for 
dipyrimidine sites that are prone to UV-induced cyclobutane pyrimidine dimers (CPD) 
and pyrimidine (6-4) pyrimidone (6-4 PP) photoproduct formation. To examine the 
efficiency of CPD and 6-4 PP formation and removal at telomeres, we irradiated BJ-
hTERT fibroblasts with UVC and purified telomeres from genomic DNA extracted at 
various repair times.  Photoproducts were quantitated by immuno-spot blotting.  Using 
this approach we observed approximately 2-fold fewer photoproducts in telomeres, 
compared to the bulk genome. CPD removal was slow, but removal from telomeres was 
1.5-fold faster compared to the bulk genome. Complete 6-4 PP removal was rapid and 
achieved by 6 hours post exposure in both bulk genomic DNA and telomeres.  
Telomerase was not required for telomeric photoproduct reduction, since telomerase 
negative U2OS cells also exhibited 6-4 PP removal from telomeres at rates similar to the 
bulk genome.  To determine whether nucleotide excision repair (NER) was responsible 
for telomeric photoproduct removal, we measured 6-4 PPs in telomeres isolated from 
UVC irradiated XPA mutant fibroblasts lacking NER. No significant reduction in 6-4 PPs 
was observed in telomeres or bulk genomic DNA by 12 hours post exposure.  
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Furthermore, we found that unrepaired photoproducts strongly inhibited binding of the 
essential telomeric protein TRF1 to telomeric DNA in vitro. Our findings provide new 
evidence that NER restores damaged telomeric DNA. 
2.2 SIGNIFICANCE 
Ultraviolet (UV) light generates DNA photoproducts in the genome that can cause 
mutations or chromosome breaks by interfering with DNA replication. Telomeres at 
chromosome ends are essential for genome stability, and we discovered that UV 
photoproducts strongly inhibit binding of telomeric protein TRF1 to telomeric DNA. 
Nucleotide excision repair (NER) removes UV photoproducts from genomic DNA, but 
whether this pathway functions at telomeres was unresolved. We developed a direct 
quantifiable assay to measure UV photoproducts at telomeres purified from UV irradiated 
human cells.  Using this approach we discovered the two most common photoproducts 
form at telomeres, and are removed at rates similar to the bulk genome.  Telomeric 
photoproduct removal requires XPA protein, providing direct evidence that NER restores 
damaged telomeres.   
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2.3 INTRODUCTION 
Genomic stability is essential for cellular health and survival. Since DNA damage from 
environmental and endogenous sources is inevitable, mechanisms for subsequent repair 
and restoration to undamaged DNA are required. Ultraviolet (UV) light exposure 
generates DNA photoproducts in which two adjacent pyrimidines are covalently joined 
to form cyclobutane pyrimidine dimers (CPD) or pyrimidine (6-4) pyrimidone 
photoproducts (6-4 PP) [108].  Unrepaired photoproducts are highly mutagenic and 
interfere with DNA replication and transcription [109, 110].  Cellular mechanisms for 
managing photoproducts include global genome repair, transcription coupled repair or 
translesion DNA synthesis [107, 111, 112].  Mammalian nucleotide excision repair (NER) 
accomplishes CPD and 6-4 PP removal using an array of 30 different proteins [107].  
Mutations in any one of seven NER proteins, including XPA protein, cause NER 
deficiency and the severe sunlight sensitivity and skin cancer prone disorder xeroderma 
pigmentosum (XP) [79].  Global genome NER involves damage recognition and 
verification, dual strand incisions flanking the lesion, repair synthesis and strand ligation 
[113].  Transcribed genes are repaired more rapidly than non-transcribed genes by the 
transcription-coupled NER pathway, which initiates when the RNA polymerase stalls at 
the lesion [112].  Finally, DNA polymerase  can accurately bypass CPDs during DNA 
replication to enable replication fork progression [114].  These mechanisms are essential 
for preserving the genome in the face of bulky lesions.    
 
Both UV irradiation and telomere shortening are associated with skin aging and 
increased skin cancer risk [79, 115].  Critically short or dysfunctional telomeres at 
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chromosomal ends trigger cell growth arrest or apoptosis that drive aging-related 
diseases and pathologies, or chromosomal alterations that drive carcinogenesis [116, 
117]. Furthermore, shortened telomeres were observed in sunlight or UVB exposed skin 
tissue from humans and mice [89, 104, 118] suggesting a link between sunlight exposure 
and telomere maintenance. Human telomeres at chromosome ends consist of about 
1500 tandem TTAGGG repeats, terminating with a 3’ single stranded overhang that 
averages 100 nucleotides in length [9, 119].  Previous studies demonstrate that telomeric 
repeats are susceptible to CPD formation following UV exposure [86, 87].  The 6-member 
shelterin protein complex at telomeres interacts with, and regulates, enzymes in every 
known DNA repair pathway including the NER endonuclease XPF-ERCC1 [92, 120].  
Shelterin prevents inappropriate telomere processing by DNA repair enzymes, and 
inhibits homology directed repair and DNA double strand break repair at telomeres [9, 
94]. However, whether NER proteins function at damaged telomeres remains 
unresolved.  Previous indirect approaches for lesion detection at telomeres led to 
equivocal results and were limited to CPD analysis in wild type cell lines [86, 87]. 
 
Here we describe a novel direct approach to study NER at telomeres in which we isolated 
telomeres from UVC irradiated human cells and detected UV photoproducts using lesion 
specific antibodies and DNA blotting. Using this approach we discovered that both CPDs 
and 6-4 PPs form at telomeres, but at levels approximately 2-fold lower compared to the 
bulk genome. We observed CPDs were removed from telomeres 1.6-fold faster than 
from the bulk genome, while 6-4 PPs were removed at similar rates. Furthermore, DNA 
photoproducts persisted at telomeres in NER deficient cells from an XP-A patient. 
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Unrepaired photoproducts strongly inhibited shelterin TRF1 protein binding to telomeric 
DNA in vitro, suggesting that an accumulation of unrepaired lesions over time could 
compromise telomere integrity. To our knowledge, these studies provide the first 
evidence that NER is active at telomeres, and that NER functions to restore telomeric 
DNA that is damaged by UV light.  
2.4 MATERIALS AND METHODS 
2.4.1 Gel shift assays 
Recombinant 6x-histidine tagged human TRF1 protein was purified from a baculovirus 
insect cell expression system as described [39]. Oligonucleotides (Table 1) for substrate 
preparation were purchased from Midland Certified Reagents Co. The CTRL or UV 
oligonucleotides were 5’ end labeled with [-32P]- ATP and Optikinase enzyme, and 
annealed to oligonucleotide TLS in a 1:2 molar ratio in 50 mM LiCl as described [39]. 
TRF1 DNA binding assays were performed as previously described [39], with substrate 
and protein amounts as indicated in the figure legends. The reactions were separated 
by gel electrophoresis on a 5% 29:1 (bisacrylamide:acrylamide) native gel at 4oC and 
140V for about 2 hours in 1X TBE buffer and visualized with a Typhoon 9400 
Phosphoimager.  Bound and unbound substrates were quantitated using ImageQuant 
software, and the percent bound was calculated as previously described [39] after 
correcting for background in the no enzyme control. 
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2.4.2 Cell culture and exposures 
Telomerase immortalized human foreskin fibroblasts BJ-hTERT cells were obtained from 
ATCC. The SV40-immortalized NER deficient human skin fibroblasts (GM04312) derived 
from an XP-A donor (XP20S) was obtained from the Coriell Cell Repository.  This cell 
line harbors homozygous inactivating mutations in gene encoding XPA protein. Cells 
were grown at 37oC and 5% CO2 in DMEM complete media containing 10% fetal bovine 
serum, penicillin (50 units/ ml) and streptomycin (50 g/ ml) (Life Technologies). UVC 
irradiation was performed via a 254 nm wavelength emitting germicidal lamp on cells at 
80% confluency in dishes lacking media.  UVC exposures were measured with a UVX31 
meter (UVP, Upland, CA). After exposures cells were incubated in fresh media, then 
washed with PBS and harvested at various repair time points. 
2.4.3 Cell viability and proliferation assays 
For short term proliferation assays the cells were UVC irradiated (10 J/m2) or not in 60 
mm dishes, incubated in fresh media, and then counted in duplicate at various repair 
time points (0 to 72 hours) using a Beckman Coulter Z1 Cell Counter.  The average cell 
number for each repair time point was divided by the cell number at 0 hour recovery. Cell 
viability was determined by trypan blue exclusion. Percent viability was calculated as 
[1.00 – (number of blue cells ÷ number of total cells)] × 100. For long term cell viability 
assays cells were irradiated with UVC (0, 5 or 10 J/m2) or not (untreated) and incubated 
in fresh media. After 6 hours of recovery the cells were collected by trypsinization and 
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counted, and then subcultured by seeding equal numbers of cells per 10-cm culture dish 
in duplicate. Following a seven day subculture, the cells were then counted. 
2.4.4 Genomic DNA and telomere purification 
Genomic DNA was isolated from harvested cells using the Qiagen 20/G or 100/G DNA 
isolation kit. Approximately 20x106 cells were harvested from eleven 100 mm dishes to 
yield about 100 g of bulk genomic DNA per repair time point. Telomeres were isolated 
as previously described with some modification [119]. Double stranded genomic DNA 
(100 g) was digested overnight with AluI, HinfI, HphI and MnlI (0.5 U/g) restriction 
enzymes in 250 l reaction volume to release intact telomeric fragments. Reactions 
were adjusted to 1x SCC and 0.1% Triton X-100, and the digested DNA was then 
annealed with a biotinylated oligonucleotide (3.5 pmoles) by controlled stepwise cooling 
from 80oC to 25oC (1.2oC/min) using a thermocycler. Then streptavidin-coated magnetic 
beads (18 l, Invitrogen, M-280) pre-washed with 1x PBST and blocked with 5x 
Denhardt's solution, were incubated with the annealed samples overnight in a rotator 
end-over-end at 6 rpm and 4oC. Beads were collected against the side of the tubes by 
applying a magnet (Invitrogen), and unbound supernatants and subsequent washes 
were collected.  The beads were washed three times with 1x SSC/0.1% Triton X-100, 
twice with 0.2x SSC and once with elution buffer [1mM Tris pH 7.5, 1mM EDTA, 10mM 
LiCl]. Beads were resuspended in 100 l elution buffer and telomeres were slowly eluted 
by heating the tubes at 50oC for 40 minutes. Telomeric DNA in the various fractions was 
quantitated by ImageQuant analysis of PhosphorImager scans of spot blots hybridized 
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with a mix of 32P-(CCCTAA)4 and 32P-(TTAGGG)4 radiolabeled oligonucleotides as 
described [121]. The fraction of telomeric DNA recovered was calculated as [bound  
(bound + unbound fraction)]; the unbound fraction was the total collected supernatant 
and wash fractions. The concentration of genomic DNA and recovered purified 
telomeres was quantitated using a Thermo Scientific NanoDrop 3300 
fluorospectrometer which accurately measures concentrations in the picogram/µl range. 
2.4.5 Telomere restriction fragment analysis 
Terminal restriction fragment analysis was performed as described previously [122, 123] 
with modifications.  Undigested genomic DNA (1 g), digested genomic DNA (3 g) or 
purified telomeres (1 ng) were separated by molecular weight by gel electrophoresis on 
a 0.6% agarose gel.  Gels were dried, stained with SYBR Green and imaged with a 
Typhoon fluorescent imager to visualize the molecular weight marker and undigested 
genomic DNA.  Next, the gel was denatured in NaOH solution, neutralized, and 
hybridized with a 32P-(TTAGGG)4 oligonucleotide probe.  Gels were subsequently 
washed and visualize via a Typhoon phosphorimager.  Telomere length measurement 
was performed using ImageQuant and the Telorun method 
(http://www4.utsouthwestern.edu/cellbio/shay-wright/research/sw_lab_methods.htm) as 
described [122].  The exACTGene 24kb Max DNA molecular weight ladder was from 
Fisher Scientific.  
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2.4.6 Immuno-spot blot detection of DNA photoproducts 
Immuno-spot blots of purified genomic, lambda and telomeric DNA were performed 
using the GE Manifold spot blot apparatus as described previously [124]. For each 
experiment nanogram amounts of telomeric DNA was loaded with the corresponding 
genomic DNA (loaded in duplicates) for each recovery time point.  For 6-4 PP detection, 
purified telomeric fractions were combined from two independent exposure experiments 
(100 g genomic DNA collected from each experiment for a total of 200 g).  Positively 
charged Hybond H+ membranes and Whatman filter papers (GE Healthcare Life 
Sciences) pre-incubated with 2x SSC buffer were assembled onto the apparatus and 
heat-denatured (100oC, 10 minutes) DNA samples were loaded on the membrane via 
vacuum blotting. Membranes were removed and placed DNA face-down on filter papers 
saturated with denaturation buffer (1.5 M NaCl/0.5 N NaOH) followed by neutralization 
buffer (1 M NaCl/0.5 M Tris-HCl pH 7.0). Membranes were then vacuum dried between 
filter papers at 80oC for 2 hours. Dried membranes were blocked for 1 hour with 5% 
non-fat dry milk in 1x PBST and incubated overnight with primary antibody against CPDs 
(1:000, clone KTM53 Kamiya Biomedical) or 6-4 PPs (1:1000, clone KTM53 Cosmo 
Bio). The Kamiya CPD antibody reacts specifically with thymine dimers produced by UV 
irradiation in double- or single-stranded DNA while the Cosmobio 6-4 PP antibody binds 
to 6-4 PPs formed in single-stranded DNA and at every dipyrimidine sequence (TT, TC, 
CT, CC). Membranes were washed with PBST and incubated for 1 hour with secondary 
antibody (anti mouse-HRP). Amersham ECL Primer (GE Healthcare) was used to 
enhance the peroxidase activity on the membranes that were immediately exposed to 
X-ray films (Phoenix Research products).  Antibody signal intensities were quantified by 
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ImageJ software.  Blots were subsequently hybridized with a mix of 32P radiolabelled 
(CCCTAA)4 and (TTAGGG)4 probes for telomeric DNA, visualized by Phosphorimager 
and quantified by ImageQuant as previously described [121].  Finally, blots were then 
hybridized with a 32P labeled probe complementary to Alu repeat DNA (Table 1), and 
processed as described for the telomeric probe.    
2.4.7 Quantitative PCR detection of DNA photoproducts 
Quantitative PCR (qPCR) based quantification of DNA lesions on λ DNA (New England 
Biolabs) exposed in vitro to UVC irradiation was carried out based on a previously 
established method [125, 126]. The qPCR assay to quantify DNA lesions is based on 
the principle that any DNA lesion that greatly impedes or blocks progression of DNA 
polymerase will inhibit the extension step. Quantification of lesion frequency is based 
on the Poisson equation, which requires the assumption that DNA lesions are randomly 
distributed. The lesion frequency per DNA strand (average for both strands) is 
calculated as: lesion frequency/amplified strand: λ=-ln(AD/Ao), where AD=Amplification 
of damaged template, Ao=Amplification of non-damaged template.  
 
2.4.8 Statistical analysis 
All statistical analyses were done using OriginPro 8 software. A two-factor Analysis of 
Variance (ANOVA) was used to determine whether the difference between the curves 
for telomeric and genomic CPD repair was significant (Fig. 8B) and to determine 
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significance of differences between telomeric and genomic 6-4 PPs at 0 hour (Fig. 10B). 
A two-tailed heteroscedastic Student’s t-test was used to determine significance of 
differences between the genomic CPDs and telomeric CPDs at 0 hour (Fig. 8B). A one-
factor ANOVA with multiple comparisons was used to determine significance of 
differences between genomic CPDs within time points for all repair experiments.  
 
 
Table 1. Oligonucleotides used in the study 
Oligo name Sequence (5’ ->3’) 
Ctrl GTGGATCCGTACTTAGGGTTAGGGTTAACACGAATTCGA 
UV GTGGATCCGTACTTAGGGT<>TAGGGTTAACACGAATTCGA 
TPL TCGAATTCGTGTTAACCCTAACCCTAAGTACGGATCCAC 
Capture oligo 
(Telomere) 
 
Bio-ACTCC (CCCTAA)3 
Capture oligo 
(Scrambled) 
 
Bio-ACTCC(CATCAG)3 
32P- Telomere (TTAGGG)4 and (CCCTAA)4 
32P - (Alu)n 
GGCCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGG
AGGCCGAGGCGGGCGGA 
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2.5 RESULTS 
2.5.1 Purification of telomeres from human cells 
To study NER at telomeres we established an assay to directly measure photoproducts 
in telomeres isolated from UV exposed cells.  Since telomeres represent less than 
0.026% of the human genome, we required large amounts of genomic DNA to obtain 
sufficeint telomeres for analysis. We chose highy proliferative BJ skin fibroblasts 
engineered to express exogenous telomerase at an early passage prior to significant 
telomere shortening [127].  Telomeres were isolated from UVC irradiated and untreated 
human cells by annealing a biotinylated oligonucleotide that was complementary to the 
G-rich telomeric single strand overhang [119]. The telomere/oligonucleotide complexes 
were captured with streptavidin-coated magnetic beads and washed, followed by the 
analysis of purified telomeres by spot blotting onto membranes (Fig. 6A).  To obtain 
telomeric fragments, and to minimize the presence of sub-telomeric DNA, we digested 
the bulk genomic DNA with a cocktail of four frequent cutter restriction enzymes that do 
not recognize or cleave telomeric sequences [123]. Agarose gel resolution revealed that 
the bulk genome was completely digested to fragments of  one kb (Fig. 7). To examine 
the integrity of the purified telomeres we resolved the telomeric fragments obtained prior 
to purification (Fig. 6B, lane 3, digested) and after purification (lane 4, purified), on a 
0.8% agarose followed by Southern blotting and hybridization with a radiolabeled 
telomere specific probe.  This analysis revealed that the average telomere length in our 
BJ-hTERT cell line is 17  1.1 kb (mean  SD from three independent experiments), and 
that the purified telomeres remained intact, although they migrated slightly slower than 
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the unpurified telomere fragments (compare lanes 3 and 4, Fig. 6B).  We suspect the 
elution of the telomeres at 50oC may allow for some partial duplex melting and potential 
secondary structure formation that could retard the fragments during migration. This 
analysis indicates that any reduction in photoproducts observed in the repair 
experiments could not be attributed to telomere degradation during the isolation 
procedure.   
 
To test the efficiency and specificity of telomere pulldown, we performed capture assays 
in the absence of biotinylated oligonucleotde (mock), with a biotinylated non-telomeric 
oligonucleotide (scrambled) or a biotinylated oligonucleotide containing (CCCTAA)3 
telomeric sequence (Table 1). From 100 g of digested genomic DNA each, we 
recovered no detectable DNA for the mock, 2.6 nanogram (ng) for the scrambled control, 
and 10 ng for the telomeric oligonucleotide (Fig. 6C).  Supernatant, wash and eluents 
from the three capture experiments were loaded onto a membrane and hybridized with 
a radiolabelled telomeric probe. The signal intensity obtained for 5 ng of the eluent from 
the telomere capture oligonucleotide, compared to that obtained for 5 ng of input DNA, 
indicates very strong enrichment for telomeres (Fig. 6C). The average efficiency of 
telomere purification was 33  0.06% (3 independent experiments), calculated as [bound 
 (bound + unbound)], and agreed with previous reports [119].  This value closely 
matches the recovery efficiency of 38% calculated by measuring DNA yields (see 
Materials and Methods for calculation). The actual telomere yield of 10  1.3 ng was 
divided by maximal telomere yield (26 ng) from 100 g of genomic BJ-hTERT DNA 
(average from five independent experiments). Similar telomere yields of 10  3 ng were 
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obtained from cells following UVC irradiation at 10 J/m2, indicating that UV photoproduct 
formation did not alter the efficiency of telomere isolation.  
 
In order to estimate the purity of the eluted telomeres we loaded various amounts of input 
(genomic DNA) and 10 ng of purified telomere eluent, followed by hybridization with a 
radiolabeled probe against Alu repeat DNA (Fig. 6D). Alu repeats are short interspersed 
elements that comprise ~10% of the genome and are commonly used as a negative 
control for identifying telomere binding proteins in ChIP assays [128, 129].  Based on 
signal intensities quantified for genomic DNA, the total amount of non-telomeric DNA 
present in the telomere eluent is approximately 1.2 ± 0.2 ng (mean  SD from two 
independent experiments) (Fig. 6E). This indicates that at least 90% of the DNA present 
in the eluent is enriched telomeres. 
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 (A) Schematic of telomere capture assay. Telomeres (blue lines) are released by digesting the 
genome (scissors) and captured by annealing a biotinylated oligonucleotide (red) that binds to 
the telomeric single strand overhang and to streptavidin beads (green).  Triangles denote 
photoproducts.  (B) Undigested (lane 2) and digested (lane 3) genomic DNA, and isolated 
telomeres (lane 4) from BJ-hTERT cells were electrophoresed on a 0.6% agarose gel that was 
subsequently hybridized with a radiolabeled telomeric probe (lane 2-4). The ladder was 
visualized by SYBR Green staining (lane 1). (C) Specificity of telomere capture. Telomeres were 
isolated using three different conditions: mock (no oligonucleotide), scrambled (non-telomeric 
oligonucleotide) and telomere oligonucleotide (Table 1).  Various amounts of digested genomic 
DNA (input), 50% of the unbound (s’nat) and 50% of the combined washes were loaded on the 
membrane.  50% of the eluent for the telomere oligo (5 ng) and total eluent for the mock (0 ng) 
and scrambled oligo (2.6 ng) was loaded.  The membrane was hybridized with radiolabeled 
telomeric probes and exposed to a phosphoimager screen for the indicated times. (D) Telomere 
purity.  Various amounts of digested genomic DNA (input) and 10 ng of the telomere eluent were 
loaded on a membrane that was hybridized with a radiolabeled Alu repeat DNA probe. (E) Alu 
signal intensities from the genomic DNA were plotted against the DNA amounts loaded. Values 
and error bars represent the mean and SD from two independent experiments. The Alu signal 
intensity for 10 ng of telomere eluent corresponded to about 1.2 ng (arrow).  
 
Figure 6: Telomere isolation assay 
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Genomic DNA isolated from untreated or 10 J/m2 UVC exposed BJ-hTERT cells and 
recovered at various time points (12 – 48 h) was digested overnight with a cocktail of 
four restriction enzymes as described in Materials and Methods. Aliquots of uncut or 
digested DNA (400 ng) were resolved on a 0.8% agarose gel at 110 V for 1 hour.  
Ethidium bromide staining reveals that the genomic DNA was digested to fragments < 1 
kb in length. 
 
Figure 7: Restriction enzyme digestion of genomic DNA 
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2.5.2 BJ-hTERT telomeres exhibit formation and removal of CPDs and 6-4 PPs 
Photoproduct removal in genomic and telomeric DNA of NER proficient BJ-hTERT cells 
exposed to 10 J/m2 UVC was quantified at various recovery times by immuno-spot blot 
assay. This exposure generated approximately 3.6 CPDs per 10 kb of genomic DNA 
(Fig. 11), in general agreement with previous reports [37, 50].  This value was derived 
by comparing signal intensities from CPD immunodetection in genomic DNA to those 
obtained from lambda DNA standards for which the UV lesion frequencies were 
determined by quantitative PCR [125] (Fig. 11). We confirmed previous reports that 
CPDs form in telomeric DNA [86, 87].  However, the CPD signal for equal amounts (7 
ng) of loaded bulk telomeric DNA at 0 hour recovery was on average 2.6-fold ( 0.32) 
lower compared to that for bulk genomic DNA (Fig. 8A, top panel).  This equates to about 
1.4 CPD/10 kb of telomeric DNA, or 2.3 CPDs per 17 kb telomere.  The CPD signal 
decreased progressively with increasing recovery time after the 10 J/m2 UVC exposure 
for both bulk genomic and telomeric DNA, however, the reduction was 1.5-fold more 
rapid for telomeric DNA (Fig. 2B). The rate difference was based on the slopes calculated 
from the linear portions of the curves (0 to 24 hrs).  The difference between the curves 
for telomeric versus genomic CPD repair is statistically significant (p = 0.0034, two-factor 
ANOVA).  Subsequent hybridization with the radiolabelled telomeric probe confirmed 
successful enrichment of telomeric DNA in the purified samples and equal loading of 
telomeric DNA for each recovery time point (Fig. 8A).  Membrane stripping led to 
telomere loss, therefore, membranes were subsequently hybridized with the radiolabeled 
Alu repeat DNA probe to confirm equal loading of the genomic DNA samples.  
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To ensure that the reduction in CPDs was not due to dilution through cell division, we 
examined cell proliferation by obtaining cell counts for each repair time point after the 10 
J/m2 UVC exposure. UVC irradiation normally triggers transient cell cycle arrest [130]. 
Untreated BJ-hTERT cells doubled in number by 48 hours, while the UVC exposed cells 
failed to double even after 72 hours recovery (Fig. 9A). However, about 95% of the cells 
harvested collected via trypsinization for the repair assay were alive as determined by 
trypan blue staining (Fig. 9B).  These results confirm that repair assays were conducted 
on viable cells, and that the observed reductions in photoproducts were not due to cell 
division. 
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(A) Cells were untreated or exposed to 10 J/m2 UVC followed by harvesting at various 
repair times (0 - 48 h). Telomeres were isolated from purified genomic DNA (100 g each 
time point) and loaded on blots (7 ng, lane 2) with equal amounts of genomic DNA (7 ng, 
loaded in duplicate lanes 1 and 3). The blot was sequentially probed with a CPD 
antibody, a radiolabeled telomere probe, and a radiolabeled Alu repeat probe. The 
telomere probes remained bound (hashed box) since membranes could not be stripped 
without losing DNA.  (B) The CPD signal intensity was quantitated, normalized to 0 hour, 
and plotted against recovery time.  Values are the mean and SE from three independent 
experiments. The difference between the curves is statistically significant (**, p = 0.0034) 
by two-factor ANOVA.  
 
Figure 8: Quantification of CPD formation and removal in telomeres from UVC 
exposed BJ-hTERT cells 
 
50 
 
(A) Cells were exposed to 10 J/m2 UVC, incubated in fresh media, and then counted 
after each recovery time point (0-72 h). Cell counts were normalized to the 0 h and 
plotted against recovery time.  Values and error bars are from means and SE from three 
independent experiments. (B) Cells were exposed to 10 J/m2 UVC, incubated in fresh 
media, and then harvested after each recovery time point (0-48 h) by trypsinization after 
washing.  Cells were counted manually on a hemocytometer for total cells and Trypan 
blue positive dead cells. Percent viability was calculated as described in Materials and 
Methods. Values represent the mean and SE from three independent experiments. (C) 
Cells were exposed to 0, 5, or 10 J/m2 UVC, recovered for 6h, sub-cultured and counted 
after 7 days of incubation.  Survival was calculated as percent of untreated and plotted 
against UVC dose. Values and error bars are means and SE from three independent 
experiments. 
 
Figure 9: UVC sensitivity and proliferation of BJ-hTERT and XP-A cells 
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The other common photoproduct 6-4 PP had not been previously examined at telomeres.  
6-4 PP lesions induce greater distortion in the duplex DNA and are repaired more rapidly 
than CPDs, however, they are formed at a lower frequency [131, 132]. The 10 J/m2 UVC 
exposure generated about 1.4 6-4 PPs per 10 kb of genomic DNA (Fig. 11). Therefore, 
higher amounts of loaded purified telomeres (15 ng isolated from 200 g genomic DNA) 
were required for reliable 6-4 PP detection.  Following 10 J/m2 UVC, the 6-4 PP signal 
was on average 1.9-fold ( 0.32) lower for bulk telomeric DNA, compared to equal 
amounts (15 ng) of bulk genomic DNA (Fig. 10A). This equates to approximately 0.74 6-
4 PPs/10 kb telomeric DNA, or 1.2 6-4 PPs per 17 kb telomere. 6-4 PPs were removed 
at similar rates in bulk genomic DNA compared to telomeric DNA, and were removed 
more rapidly than CPDs (Fig. 10B). About 20% of the 6-4 PPs remained in both genomic 
and telomeric DNA by 3 hours and only ~6% remained by 6 hours post UVC exposure. 
Hybridization with telomeric and Alu repeat specific probes confirmed equal loading of 
telomeric DNA and genomic DNA, respectively, for all time points (Fig. 10A). The 
difference between the genomic CPDs and telomeric CPDs formed at 0 hour is 
statistically significant (**, p = 0.0031) by two-tailed heteroscedastic Student’s T test.  
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 (A) Cells were untreated or exposed to 10 J/m2 UVC followed by harvesting at various 
repair times (0 - 12 h). Telomeres were isolated from purified genomic DNA (100 g each 
time point) and combined from two separate experiments to obtain 15 ng (lane 2) for 
loading. Genomic DNA was loaded at 7.5 ng (lane 1) and 15 ng (lane 2). The blot was 
sequentially probed with a 6-4 PP antibody, a radiolabeled telomere probe, and a 
radiolabeled Alu repeat probe. (B) The 6-4 PP signal intensity was quantitated, 
normalized to 0 hour, and plotted against recovery time.  Values are the mean and SE 
from four independent experiments for genomic DNA and two experiments for telomeric 
DNA. Differences between genomic and telomeric 6-4 PPs at 0, 3 and 6 hours after UVC 
exposure were not statistically significant by two-factor ANOVA. 
 
Figure 10: Quantification of 6-4 PP formation and removal in telomeres from UVC 
exposed BJ-hTERT cells 
 
 
53 
 
N
o
: 
o
f 
le
s
io
n
s
/1
0
 k
b
 
54 
 (A) Lambda DNA standards were prepared by exposing naked DNA to 0, 5, 10 or 20 
J/m2 UVC. Total UV photoproducts were measured by qPCR. The number of CPDs and 
6-4 PPs were deduced by applying the previously reported ratio of three CPDs for one 
6-4 PPs formed.  (B) Lambda DNA standards (3 ng) were loaded in triplicate on a 
membrane and immunoblotted for CPDs. Signal intensities were plotted as a function of 
the CPD number to generate a standard curve. (C) The CPD signal intensity was 
measured for BJ-hTERT genomic DNA from untreated or 10 J/m2 UVC exposed cells (3 
ng) loaded on the same blot as the lambda DNA standards.  The number of CPDs (right 
panel) was deduced from from the lambda standard curve. (D) Lambda DNA standards 
(7 ng) were loaded in triplicate and immunoblotted for 6-4 PPs. Signal intensities were 
plotted as a function of 6-4 PPs number to generate a standard curve. (E) The 6-4 PP 
signal intensity was measured for BJ-hTERT genomic DNA from untreated or 10 J/m2 
UVC exposed cells (7 ng) loaded on the same blot as the lambda DNA standards.  The 
number of 6-4 PPs (right panel) was deduced from the lambda standard curve.  Values 
for lambda DNA standard curves represent the mean and SE from three independent 
blots, and values from genomic DNA represent mean and SE from three independent 
experiments. 
 
Figure 11: Estimation of CPDs and 6-4 PPs in BJ-hTERT genomic DNA after UVC 
exposure 
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2.5.3 Removal of 6-4 PPs at telomeres depends on XPA protein 
To determine whether photoproduct removal at telomeres requires NER, we repeated 
the telomere capture and immuno-spot blot assays in cells lacking repair. NER deficent 
skin fibroblasts were obtained from an XP-A individual and were immortalized by SV 40 
transformation [133]. We first confirmed that the XP-A cells were more sensitive to UVC 
compared to repair proficient BJ-hTERT cells by conducting a long-term survival assay 
[134]. For this experiment cells were exposed to UVC and allowed to recover for 6 h, 
then sub-cultured for 7 days and counted (Fig. 9C).  Although sensitive to UVC, the XP-
A cells harvested shortly after UVC irradiation for the repair assays were at least 95% 
viable as determined by trypan blue staining (Fig. 9B).  Genomic DNA isolated from XP-
A cells lacked 6-4 PP and CPD repair up to 3 or 12 hours, respectively, post UVC 
exposure (Figs. 12A and 13A). Similarly, there was no significant change in the amount 
of 6-4 PPs in bulk telomeres by 3 hours, compared to 0 hours, post UVC exposure (Figs. 
12A and C). We repeated this experiment except that we allowed the cells to recover for 
12 hours, and still did not observe a significant reduction in 6-4 PPs in either bulk 
genomic or telomeric DNA (Figs. 12B and C).  These results validate our approach for 
the ability to detect a lack of repair in telomeres, and provide evidence that NER is active 
at  telomeres and removes photoproducts. 
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(A) Cells were exposed to 10 J/m2 UVC and harvested at various repair times (0, 1.5 and 
3 h, experiment a; 0 and 12 h, experiment b). Telomeres were isolated from purified 
genomic DNA (100 g each time point) and combined from two separate experiments to 
obtain 13-14 ng (lane 2) for loading. Genomic DNA was loaded at amounts indicated. 
The blots were sequentially probed with a 6-4 PP antibody, a radiolabeled telomere 
probe, and a radiolabeled Alu repeat probe. (B) The 6-4 PP signal intensity was 
quantitated, normalized to 0 hour, and plotted against recovery time.  Genomic DNA 
values represent the mean and SE from two independent experiments, and values for 
telomeres are from blots shown in A. (experiments a and b). Differences between 6-4 
PPs repaired at 0, 3 and 12 hour in genomic DNA after UVC exposure were not 
statistically significant by one-factor ANOVA with multiple comparisons. 
 
Figure 12: XPA protein is required for 6-4 PP removal from telomeres 
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 (A) Cells were exposed to 10 J/m2 UVC followed by harvesting at various repair times. 
Genomic DNA was loaded (10 ng) in duplicate on a membrane which was sequentially 
probed with CPD antibody and then a radiolabeled Alu repeat probe. (B) The CPD signal 
intensity was quantitated, normalized to 0 hour, and plotted against recovery time.   
Values and error bars are means and SE from three independent experiments. 
Differences between CPDs at 0, 12, 24 and 48 hours in genomic DNA after UVC 
exposure were not statistically significant by one-factor ANOVA with multiple 
comparisons. 
 
Figure 13: Quantification of CPD formation and removal in genomic DNA 
 from UVC exposed XP-A cells 
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Finally, 6-4 PP removal from telomeric DNA was not dependent on telomerase. We 
observed nearly complete removal of 6-4 PP in both bulk genomic and bulk telomeric 
DNA by 12 hours post UVC in the telomerase negative human osteosarcoma cell line 
U2OS (Fig. 14).  The initial amount of 6-4 PPs formed in telomeric DNA from U2OS cells 
was about 2-fold lower compared to bulk genomic DNA, similar to BJ-hTERT cells (Fig. 
14). Repair rates of both 6-4 PP and CPDs in genomic DNA were slower in U2OS cells 
compared to BJ-hTERT (Figs. 14-15). In summary, we observed that 6-4 PPs form at 
telomeres following UVC exposure and are removed at rates similar to the bulk genome. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
59 
 
 
 
 
(A) Cells were untreated or exposed to 10 J/m2 UVC and harvested at various repair 
times (0 - 12 h). Telomeres were isolated from purified genomic DNA (200 g each time 
point) and loaded on a membrane (15 ng) (lane 3). Genomic DNA was loaded at 15 ng 
(lane 1) and 7.5 ng (lane 2). The blot was sequentially probed with a 6-4 PP antibody, a 
radiolabeled telomere probe, and a radiolabeled Alu repeat probe. (B) The 6-4 PP signal 
intensity was quantitated, normalized to 0 hour, and plotted against recovery time.  
 
Figure 14: Quantification of 6-4 PPs formation and removal in telomeric 
 DNA from UVC exposed U2OS cells 
   
60 
 
 
 
(A) Cells were exposed to 10 J/m2 UVC and harvested at various repair times. Genomic 
DNA was isolated and loaded (15 or 7.5 ng) on a membrane which was sequentially 
probed with CPD antibody and then a radiolabeled Alu repeat probe. (B) The CPD signal 
intensity was quantitated, normalized to 0 hour, and plotted against recovery time.   
Values and error bars are means and SE from three independent experiments, except 
the 1.5 h time point which was from a single experiment. Differences between CPDs at 
0, 3 and 12 hours after UVC exposure were not statistically significant with one-factor 
ANOVA with multiple comparisons. 
 
Figure 15: Quantification of CPD formation and removal in genomic DNA from 
UVC exposed U2OS cells 
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2.5.4 An unrepaired cyclobutane pyrimidine dimer inhibits TRF1 binding 
We showed that photoproducts persist in cells lacking NER (Fig. 12).  Telomeres could 
potentially tolerate an accumulation of unrepaired DNA lesions if such lesions fail to 
disrupt shelterin binding.  However, previous reports show that 8-oxoguanine decreases 
TRF1 and TRF2 binding to telomeric duplexes by 50% in vitro [39]. To determine whether 
unrepaired photoproducts also inhibit TRF1 binding, we performed gel shift assays with 
purified TRF1 and a 39 bp duplex DNA substrate containing  the minimal consensus 
binding sequence for a TRF1 homo-dimer [39].  A damaged substrate was constructed 
by replacing the central adjacent thymines with a CPD lesion (Table 1).  We tested a 
CPD since it distorts the helix less than a 6-4 PPs [112] and is commercially available. 
Migration of telomeric substrates through the agarose gel was retarded due to TRF1 
binding to the duplex (Fig. 16A). The presence of a single CPD lesion within the telomeric 
substrate caused a prominent decrease in TRF1 binding to the substrate (lanes 7 to 10); 
14-fold (93%) decrease within the linear range of the binding curve (25 nM TRF1) 
compared to the control (Fig. 16B).  These data suggest that persistent CPDs at the 
telomeres could alter shelterin binding, underscoring the potential importance of repair 
at telomeres.    
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The TRF1 homo-dimer binding sequence and site specific CPD () is shown. (A) 
Substrates (2.5 nM) consisting of annealed Ctrl/TPL or UV/TPL duplexes were incubated 
with decreasing TRF1 concentrations (200, 100, 50 or 25 nM) for 20 minutes in binding 
buffer, and reactions were run on a 5% acrylamide native gel. Bound and unbound (free) 
substrate are indicated. (B) The percent bound was calculated and plotted against TRF1 
concentration. Circle and dotted line, control (Ctrl); square and solid line CPD containing 
substrate (UV). Values and error bars indicate the mean and SD from three independent 
experiments. 
 
Figure 16: A cyclobutane pyrimidine dimer inhibits TRF1 binding to 
telomeric DNA 
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2.6 DISCUSSION 
In this study we established an assay for directly visualizing and quantifying 
photoproduct formation and removal in bulk telomeres isolated from various UVC 
irradiated cell lines.  Using this approach we confirmed CPD formation in telomeres, and 
discovered that telomeres are also susceptible to 6-4 PP formation (Figs. 8 and 10).  The 
frequency of photoproducts at telomeres was about 2-fold lower compared to the bulk 
genome, suggesting that shelterin may partly shield the telomeres from damage. Using 
the telomere isolation and immunoblotting approach we observed that CPDs and 6-4 
PPs are removed from telomeres, and that lesion reduction requires the NER protein 
XPA, but does not depend on telomerase activity.  We discovered that a single 
unrepaired CPD strongly inhibited shelterin TRF1 binding to telomeric DNA in vitro, 
suggesting that unrepaired lesions at telomeres could be deleterious if they accumulate. 
To our knowledge this study provides the first direct evidence that NER is functional at 
telomeres and is required to restore damaged telomeric DNA.    
 
Our result that CPDs and 6-4 PPs are less abundant at telomeres compared to the bulk 
genome suggests that shelterin may partly protect the telomeres from UV irradiation.  
This is particularly interesting in light of evidence that naked telomeric DNA in vitro is 
more susceptible to UVC-induced CPD formation compared to control DNA containing 
similar numbers of dipyrimidine sites [86]. However, shelterin may act similarly to some 
transcription factors which can inhibit photoproduct formation at bound promoters upon 
cellular UV irradiation [135]. Furthermore, we cannot rule out the possibility that 
photoproduct formation at telomeres may be higher compared to specific sites within the 
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genome.  For example, previous work reported more CPDs at telomeric fragments 
compared to fragments from the p53 tumor suppressor gene and 28S ribosomal DNA 
(rDNA) gene after cellular UVC exposure [86]. Thus, the shelterin complex at telomeres 
may modulate susceptibility to photoproduct formation. 
 
Global genome repair (GGR) removes photoproducts and bulky lesions from both 
transcribed and silent genomic regions, whereas transcription-coupled repair (TCR) is a 
specialized mechanism limited to lesion removal on the template DNA strands of actively 
transcribed genes [112].  Therefore, our analysis of photoproduct removal from the bulk 
genome represents primarily GGR rates and is consistent with CPD and 6-4 PP rates 
reported elsewhere for human cells [86, 87, 136].  However, telomeres are transcribed 
from the C-rich strand into non-coding RNAs called TERRA which are required for 
telomere homeostasis [85, 137].  Therefore, photoproduct removal rates from telomeres 
may include TCR of CPDs at CT or CC dipyrimidines on the actively transcribed 
telomeric strand.  This may explain why we observed a 1.5-fold faster removal of CPDs 
from bulk telomeres compared to bulk genomic DNA (Fig. 8). TCR of 6-4 PPs is often 
obscured because these lesions are rapidly and efficiently repaired by GGR [112, 132, 
138], in agreement with our result that 6-4 PP removal rates are similar in bulk telomeres 
compared to bulk genomic DNA (Fig. 10). 
 
Using our telomere capture and immuno-spot blot approach we observed that only 25% 
of the detectable CPDs remain at telomeres by 24 hours of repair, and that they 
disappear by 48 hours, in BJ-hTERT fibroblasts (Fig. 8). This rate is higher than that 
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reported previously for telomere CPD removal in primary fibroblasts derived from normal 
young individuals, in which 50% of the telomeric CPDs remained by 24 hours similar to 
repair rates in non-transcribed strands [87].  However, direct comparison is difficult since 
the UV dose used was higher (20 J/m2) than in our experiments, and the primary 
fibroblasts lacked telomerase and possessed shorter telomeres; all factors that may 
influence telomere repair rates.  For example, if efficient telomere repair relies on 
transcription or TCR, perhaps differences in the levels of  telomere transcription among 
cell lines may influence the efficiency of telomere repair.  Importantly, both our approach 
and this previous approach [87] yielded the similar result that UV-induced CPDs are 
removed from telomeres during recovery.  These approaches have in common the 
detection of CPDs in telomere restriction fragments either by antibody staining of isolated 
telomeres (this study) or by T4 endonuclease cleavage of unpurified telomere fragments 
[87].  
 
Telomeres released by restriction enzymes retain some sub-telomeric DNA that may be 
resistant to digestion. We attempted to minimize sub-telomeric DNA by using multiple 
restriction enzymes that are known to cut within the sub-telomeric regions [123].  This 
region contains degenerate telomeric repeats and is estimated to average ~3.5 kb in BJ-
hTERT cells [139].   Therefore, approximately 20% of the purified telomere fragments 
could contain sub-telomeric DNA. We cannot rule out the possibility that some of the 
CPD and 6-4 PP removal in the purified telomeres is due to repair in sub-telomeric 
regions.  However, if the telomeres were resistant to repair then photoproducts should 
have remained visible since the majority of the isolated telomeres consists of telomeric 
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DNA (Figs. 8, 10 and 12).  In constrast, we failed to detect CPDs after 48 hours and 6-4 
PPs after 6 hours of repair in telomeres from BJ-hTERT cells (Figs. 8 and 10).  Another 
possibility is that telomeres are refractory to CPD and 6-4 PP formation and that lesions 
are limited to the sub-telomeric region.  This is highly unlikely due to the small size of the 
target; 10 J/m2 induces at least one CPD per 10 kb and 6-4 PPs are about three-fold less 
frequent [63, 140]. Furthermore, a previous approach reported CPDs in telomeric DNA 
by using quantitative PCR to measure telomeric DNA, which excludes sub-telomeric 
DNA [86].     
 
Disparity between our results and a previous study that reported no significant CPD 
removal from telomeres by 48 hours [86], may be explained partly by differences in cell 
lines or approaches.  In the previous study denatured ssDNA from UV irradiated cells 
was chromatin immuno-precipitated with a CPD-antibody to isolate ssDNA fragments 
containing CPDs, followed by gene and telomeric DNA identification using quantitative 
PCR [86].  We used the reverse approach in which we isolated bulk telomeres first, and 
then blotted them on a membrane for lesion detection with the CPD or 6-4 PP antibodies. 
Telomeres present a challenge for lesion detection because the DNA must be denatured 
for the antibodies to recognize the lesion, and single stranded telomeric G-rich repeats 
can fold into G-quadruplex structures [141].  Using our approach the telomeres are 
denatured in a membrane and fixed to avoid secondary structure formation, therefore, 
we do not suspect that G-quadruplex formation could prevent lesion detection.  
Furthermore, our approach is able to detect 6-4 PPs in telomeres at all time points in 
NER-deficient cells (Fig. 12).  Perhaps, a subset of telomeres retain photoproducts but 
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are beyond the detection limit of our assay, and may be detectable by the more sensitive 
qPCR approach [86].  Another difference is that we used skin fibroblasts that are 
telomerase positive and an osteosarcoma cell line that maintains telomeres by ALT, 
rather than primary fibroblasts. A limitation of our assay is that it requires a large amount 
of genomic material and thus, highly proliferative cells. However, telomerase does not 
enable 6-4 PP removal from telomeres (Fig. 14) and previous studies also showed CPD 
removal from telomeres occurs in primary fibroblasts [87].  Another factor may be related 
to differences in transcriptional activity levels at telomeres among cell lines, which would 
influence lesion removal at telomeres by TCR as mentioned earlier.   
2.7 BIOLOGICAL IMPLICATIONS 
The finding that 6-4 PPs persist at telomeres in NER deficient cells, but are removed in 
NER proficient cells, provides strong evidence that NER is active at telomeres.  Previous 
studies of CPD formation and removal at telomeres in normal cells could not rule out the 
possibility that lesion removal was accomplished by another mechanism [87].  Shelterin 
protein TRF2 prevents inappropriate cleavage of the telomeric 3’ ssDNA overhang by 
the key NER nuclease XPF-ERCC1 [92].  Our data indicates this TRF2 inhibitory effect 
does not extend to NER. Thus, both NER (this study) and base excision repair are active 
at telomeres [40], while homologous recombination repair and non-homologous end 
joining are suppressed at telomeres [9, 94]. Together with reports that UV exposure 
apparently alters telomere lengths in tissue [89, 104, 118], our finding provides evidence 
that repair of photoproducts is likely important for telomere preservation.  Consistent with 
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this, we observed that UVC irradiation induces telomere aberrations that are 
exacerbated in cells lacking lesion bypass by polymerase , indicating that unrepaired 
photoproducts can interfere with telomere replication [142].  Furthermore, we observed 
that an unrepaired CPD inhbited TRF1 binding to telomeric DNA by 14-fold, which is 
much greater than the 2-fold inhibition caused by an 8-oxoguanine lesion on the identical 
substrate [39]. This strongly suggests that lack of lesion repair at telomeres could be 
deleterious if unrepaired lesions increase in density overtime. Our discovery that NER is 
active at telomeres is consistent with the prediction that UV photoproducts disrupt 
telomere function and therefore, need to be removed.  
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3 INVESTIGATING ROLES FOR NUCLEOTIDE EXCISION REPAIR IN 
PROTECTING TELOMERES FROM DEFECTS INDUCED BY UV IRRADIATION 
3.1 INTRODUCTION 
Unrepaired DNA photoproducts generated by exposure to UV light have the potential to 
cause deleterious effects at telomeres in several ways.  First, UV photoproducts can 
cause replication stress at telomeres, leading to telomere defects [142]. Recent evidence 
from our lab indicates that 5 J/m2 UVC exposure induces telomere aberrations in human 
skin fibroblasts, and that the amount of UV-induced telomere aberrations are greater in 
XPV cells compared to wild type [142]. XPV cells lack the translesion synthesis enzyme 
polymerase ƞ, which efficiently and accurately bypasses UV-induced CPDs to continue 
DNA replication (see section 1.2.4). UV is capable of inducing several kinds of telomere 
aberrations [142].  These include telomere losses (missing or critically short telomeres), 
telomere doublets (or ‘fragile’ telomeres) and sister telomere fusions. Importantly, 
telomere doublets are believed to result from altered condensed chromatin arising from 
regions of unreplicated ssDNA due to stalled or broken replication forks, and are induced 
by factors that also cause breakage at common fragile sites in chromosomes [11]. 
Moreover, unrepaired UV photoproducts can interfere with shelterin integrity, as strongly 
supported by our finding (see section 2.5.4) that a CPD lesion can severely inhibit TRF1 
binding to telomeric duplexes. Thus, these studies provide evidence that removal of UV 
photoproducts at telomeres is critical for preserving telomeric structure and integrity. 
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Previous studies in mice suggest that a functional NER pathway may be required to 
preserve telomeres in skin following UV exposure. XPC is a protein that participates in 
the global genome NER pathway for repair of DNA photoproducts [88]. In the recent 
study by Stout and Blasco [89] (mentioned previously in section 1.2.7), the dorsal skin 
of wild type and Xpc-/- knock out mice was chronically exposed to 1.8 kJ/m2 UVB 
radiation. Then telomere lengths and the percent of critically short telomeres in skin were 
measured by quantitative fluorescent in situ hybridization (qFISH) using telomeric 
probes. The authors observed that chronic UVB exposure caused accelerated telomere 
shortening in the skin of wild type mice that was exacerbated in Xpc-/- knock out mice. 
These findings, however, do not show unambiguously that NER was responsible for 
protecting telomeres from UV-induced shortening, because UVB causes oxidative 
damage in addition to photoproducts, and the XPC protein participates in base excision 
repair (BER) of oxidative damage [90, 91]. 
 
A functional XPA protein is indispensable for removal of UV-induced DNA photoproducts 
by the NER pathway, and loss of XPA can lead to several cellular abnormalities caused 
by defects in repairing DNA lesions [143]. However, unlike XPC, there is no current 
evidence that XPA participates in BER.  XPA is a zinc metalloprotein that binds to ssDNA 
bearing the damage or chemically altered nucleotide and participates in the lesion 
verification step of NER (see section 1.2.5). XPA also recruits structure specific 
endonuclease XPF-ERCC1 to the pre-incision repair complex, which makes an incision 
5’ to the lesion to release the strand containing the damage [144]. XPA knockdown mice 
lack NER to repair UV photoproducts in their genome, are highly susceptible to UVB-
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induced skin and eye tumors as well as enhanced inflammation and 
immunosuppression, but are otherwise normal [145].  However, UVB induction of skin 
cancer in these mice requires exposure to shaved regions. 
 
In this study we set out to test the hypothesis that a functional NER pathway suppresses 
the formation of UVC-induced telomeric defects. In order to address this hypothesis, we 
performed telomere FISH on metaphase chromosomes from an NER deficient XPA 
mutant cell line (XP-A), compared to an isogenic XPA complemented cell line (XPAC), 
to score for telomere defects after 0, 5 and 10 J/m2 UVC exposure. We predicted that 
the XPAC cells would be proficient for NER and would exhibit a lower number of UV-
induced telomere aberrations compared to the XP-A cells which are deficient in UV 
photoproduct repair. Previous evidence suggested that unrepaired UV photoproducts 
can cause replication stress at telomeres, leading to telomere defects [142]. However, 
we did not observe differences in the type and number of telomere aberrations induced 
by UVC exposure between the XP-A and XPAC cells. We found that the XPAC cells are 
proficient for photoproduct repair in genomic DNA, however, the repair rate was greatly 
reduced compared to wild type BJ-hTERT cells (see section 3.3.3). Western blotting of 
cell lysates revealed that the XPAC cells express much higher amounts of XPA protein 
compared to BJ-hTERT cells. We concluded that the abnormal excess of XPA protein in 
XPAC cells might have hindered normal rates of photoproduct repair, which precluded 
our ability to determine whether or not NER protects against UV-induced telomere 
defects.  However, our studies revealed that UVC irradiation of NER deficient cells 
causes an increase in telomeres loss and fragility. 
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3.2 MATERIALS AND METHODS 
3.2.1 Cell culture and exposures 
XPAC and XP-A isogenic cell lines were obtained from Coriell Institute (Camden NJ). 
The XPAC cell line (GM15876) was derived from the SV-40 transformed XP-A skin 
fibroblast cell line (GM04312). The XP-A cell line was obtained from an XP-A patient 
donor that harbored a G-to-C transversion at the 3-prime splice acceptor site of intron 3 
of the XPA gene. The XP-A patient was found to be homozygous for the mutation. The 
XPAC cell line was created by transfecting an expression vector containing the full length 
cDNA of the XPA gene into the XP-A cell line to correct for the protein deficiency [133]. 
Cells were grown at 37oC and 5% CO2 in DMEM complete media containing 10% fetal 
bovine serum, penicillin (50 units/ ml) and streptomycin (50 g/ ml) (Life Technologies). 
UVC irradiations were performed for XPAC cells exactly as described in Section 2.4.2 
for BJ-hTERT and XP-A cells.  
3.2.2 Cell viability and proliferation assays 
Similar to BJ-hTERT and XP-A cells (see section 2.4.3), for short term proliferation 
assays XPAC cells were UVC irradiated (10 J/m2) or untreated in 60 mm dishes, 
incubated in fresh media, and then counted in duplicate at various repair time points (0 
to 72 hours) using a Beckman Coulter Z1 Cell Counter.  The average cell number for 
each repair time point was divided by the cell number at 0 hour recovery. Cell viability 
was determined by Trypan Blue exclusion. Percent viability was calculated as [1.00 – 
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(number of blue cells ÷ number of total cells)] × 100. For long term cell viability assays, 
the cells were irradiated with UVC (2, 5 or 10 J/m2) or not (untreated) and incubated in 
fresh media. After 6 hours of recovery the cells were collected by trypsinization and 
counted, and then subcultured by seeding equal numbers of cells per 10-cm culture dish 
in duplicate. Following a seven day subculture, the cells were counted again. 
3.2.3 Telomere fluorescent in Situ hybridization assays 
XP-A and XPAC cells (5x105) were seeded in 35 mm dishes and grown overnight.  Cells 
were then exposed to the UVC dose (0, 5 or 10 J/m2) as indicated in the figure legend, 
and allowed to recover for 6 hours in fresh media.  Metaphase chromosomes were then 
prepared and stained as described previously [146]. Briefly, following recovery, cells 
were incubated in 0.05 g/mL colcemid for 10 hours to accumulate cells arrested in 
metaphase.  Cells were then harvested, incubated in 75 mM KCl hypotonic solution, 
fixed in 3:1 methanol:acetic acid fixative solution and dropped onto slides to spread the 
metaphase chromosomes. Telomeres were hybridized with a Cy3 labeled peptide 
nucleic acid (PNA) probe for 2 hours with the sequence (CCCTAA)3 complementary to 
the telomeres as described previously [147]. PNAs are sequence specific probes 
routinely used in hybridization assays since they lack a negatively charged phosphate 
backbone and have high affinity for DNA. Z-stack images were obtained using a Nikon 
Ti90 epi-fluorescence microscope equipped with PlanApo 60×/1.40 oil immersion 
objective.  Analysis of telomere signal free ends, fusions and aberrations was performed 
using NIS Elements (Nikon Inc., NY).  Images were then visually inspected and scored 
for telomere aberrations.  
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3.2.4 Genomic DNA purification and immune-spot blot detection of DNA 
photoproducts 
Genomic DNA was isolated from harvested cells using the Qiagen 20/G DNA isolation 
kit. Approximately 5x106 cells were harvested from two 100 mm dishes to yield about 20 
g of bulk genomic DNA per repair time point. Immuno-spot blots of purified genomic 
DNA were performed using the GE Manifold spot blot apparatus as previously described 
[124] and exactly as was described in Section 2.4.6 for BJ-hTERT and XP-A cells. 
3.2.5 Western blotting for XPA protein 
To confirm XPA complementation in XPAC cells, cell lysates were obtained from cells 
grown in 75 cm2 dishes, collected by trypsinization and washed with cold PBS.  Cells 
were resuspended in whole cell lysis buffer [50 mM Tris [pH 7.4], 150 mM NaCl, 5 mM 
EDTA, 1% Nonidet P-40, and protease inhibitor cocktail (1 μg/ml chymostatin, 1 μg/ml 
pepstatin, 1 μg/ml aprotinin, 1 μg/ml leupeptin, 0.4 μl/ml AEBSF)].  After incubation of 
the cell lysates for 30 minutes on ice, the lysate was centrifuged at 15000 xg for 20 
minutes at 4ºC.  Bradford assay (Thermoscientific) was performed according to the 
manufacturer’s protocol to quantitate total protein in the lysates. Protein (30 g) from XP-
A, XPAC and BJ-hTERT cells was loaded onto a pre-cast NuPAGE® Novex® 10% Bis-
Tris Gels polyacrylamide gel and run using NuPAGE® MOPS SDS running buffer. 
Proteins were separated by size via gel electrophoresis and then transferred onto a 
PVDF membrane. The membrane was blocked with 5% non-fat dry milk in 1X PBST 
(0.5% Tween 20) and then incubated with primary antibody against XPA (FL-273, 
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Santacruz Biotechnology, 1:200 dilution). Post incubation with horseradish peroxidase-
conjugated (HRP) secondary antibodies (1:10000), membranes were washed with 
1xPBST and visualized using enhanced chemiluminescent plus (GE Amersham).  The 
membrane was then stripped and reprobed with an antibody against Glyceraldehyde-3-
Phosphate Dehydrogenase (GAPDH) (0411, Santa Cruz Biotechnology, 1:200) as a 
loading control.   
3.2.6 Statistical methods 
Statistical analyses were performed using OriginPro 8 software. One-factor ANOVA 
along with Holm-Sidak test for comparison of means was used to determine the 
significance of differences between the three UVC exposure conditions (0, 5 and 10 
J/m2) (Fig. 18). One-factor ANOVA with multiple comparisons of means was used  to 
determine significance of differences between the five repair time-points (0, 6, 12, 24, 48 
hours) for CPDs and 6-4 PPs post UVC exposure in XPAC cells (Fig. 19). The statistically 
significant level was set at p<0.05. 
3.3 RESULTS 
3.3.1 UVC sensitivity of XPAC cells compared to XP-A cells 
Complementation of XP-A cells with functional XPA protein should increase resistance 
to UVC irradiation  [148].  To confirm this, we examined the effect of UVC irradiation on 
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long term cell proliferation and survival in XPAC cells. Following UVC exposures and 6 
h recovery, cells were sub-cultured and recovered for seven days and then counted.  We 
observed that the XPA complemented XPAC cells were less sensitive to the UVC 
exposure, compared to the isogenic NER deficient XP-A cells (Fig. 17A) (XP-A data from 
Chapter 2 is shown here again for comparison with XPAC).  
 
Next we examined cell proliferation in XPAC cells shortly after 10 J/m2 UVC exposure to 
ensure that any decrease in photoproducts during the repair time points was not due to 
dilution through cell division.   UVC exposed XPAC cells, unlike untreated XPAC cells, 
failed to double even after 72 hours recovery (Fig. 17B).  No obvious difference in UVC-
induced inhibition of cell proliferation, or reductions in cell counts, was detected between 
the XPAC and XP-A cells in this short term proliferation assay (Fig. 17B)(XP-A data from 
Chapter 2 shown for comparison).   We performed cell viability assays using trypan blue 
exclusion staining, and consistent with results obtained for BJ-TERT and XP-A cells (see 
Chapter 2), we observed that about 95% of the XPAC cells collected via trypsinization 
for subsequent repair analysis failed to stain with trypan blue dye and were thus, viable 
(Fig. 17C).  These results confirm that genomic DNA repair assays were conducted on 
viable XPAC cells, and that any observed reductions in photoproducts were not due to 
cell division. 
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 (A) Cells were exposed to 0, 2, 5 or 10 J/m2 UVC, sub-cultured and counted after seven 
days. Survival was calculated as the percent of untreated and plotted against UVC dose. 
Values and error bars are means and SE from three independent experiments. (B) Cells 
were exposed to 10 J/m2 UVC and counted at various recovery times. Cell counts were 
normalized to 0 h and plotted against recovery time. Values and error bars are means 
and SE from three independent experiments. (C) Cells were exposed to 10 J/m2 UVC, 
incubated in fresh media, washed and then harvested after each recovery time point by 
trypsinization. Cells were counted manually on a hemocytometer for total cells and 
trypan blue positive dead cells. Values are mean and SE from three independent 
experiments. 
 
Figure 17:  UVC induces sensitivity and inhibits proliferation of XPAC cells 
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3.3.2 UVC causes an increase in telomere aberrations in XP-A and XPAC cells 
A previous study by Brash and Rochette [86] showed that chronic UVB exposure does 
not induce reductions in average telomere lengths.  However, UV photoproducts might 
not form in every telomere and UV exposure may affect individual telomeres without 
causing detectable alterations in mean telomere lengths. Since unrepaired 
photoproducts are capable of creating replication blocks [149], we expected that 
replication stress associated telomeric defects would result in the absence of 
photoproduct removal by NER.  
 
To determine if UVC is able to cause telomeric defects in cells proficient and deficient in 
NER as well as to determine if NER proficiency in cells protects telomeres from forming 
aberrations, we performed the Telo-FISH assay as described in Materials and methods 
in isogenic cell lines XP-A and XPAC. Briefly, we exposed XP-A and XPAC cells to 0, 5 
or 10 J/m2 UVC, allowed recovery for 6 hours, and treated the cells with colcemid which 
inhibits spindle fiber formation and arrests cells in metaphase. We then visualized 
telomeres at chromosome ends via in situ hybridization using a fluorescent PNA probe 
that binds specifically to telomeres. 30 metaphase spreads were analyzed for each 
treatment and Z stack images were acquired. The Z stack images represent a series of 
eight 0.25 m slices acquired at different focal planes to ensure that a missing telomere 
is not just out of focus. Telomere losses manifest as signal free ends (SFEs) that lack 
PNA staining at the termini of one or both chromatids, telomere doublets (TDs) represent 
more than one telomeric PNA signal at a chromatid end, and sister telomere fusions 
(STFs) appear as a single fused PNA signal at two adjacent sister chromatid telomeres. 
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We mainly scored for telomere doublets (TDs) and telomere loss or signal free ends 
(SFEs) since telomere fusions (STFs) were found to be very rare. The number and type 
of aberrations for both cell lines were plotted against UVC dose and statistical analysis 
performed to test for significant differences between the three treatments using one way 
ANOVA and Holm-Sidak test (OriginPro 8). If NER activity at telomeres is required for 
preserving damage telomeres, we predicted that XPAC cells should be NER proficient 
and have a lower amount of telomere aberrations compared to NER deficient XP-A cells.  
 
We made five important observations following our analyses (see Fig. 18). First, we 
observed that background SFEs in untreated cells for both cell lines was high. Second, 
UVC exposure increased the number of telomere aberrations in both cell lines in a dose 
dependent manner with 10 J/m2 causing the highest number of telomere defects overall. 
Third, there was a greater induction of SFEs compared to TDs in both the cell lines for 
most cases. Fourth, there was a two-fold increase in SFEs in both the cell lines treated 
at 10 J/m2 UVC compared to corresponding untreated cells. This difference was found 
to be statistically significant, as was the difference between SFEs in untreated and 5 
J/m2 UVC treated cells for both XP-A and XPAC cell lines. Finally, the induction of SFEs 
and TDs for both 5 J/m2 and 10 J/m2 UVC treatments was similar that between the XP-
A and XPAC cell lines.  However, the difference between TDs after 10 J/m2 compared 
to untreated was only statistically significant for the XP-A cell line.  Thus, contrary to our 
original expectation, we failed to observe differences in number of UVC-induced 
telomere aberrations between XP-A and XPAC cell lines. In summary, we observed that 
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the incidence of UVC-induced telomere aberrations was not lower in XPA complement 
XPAC cell line, compared to NER deficient XP-A cells. 
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Courtesy: Laura Congelio and Connor Murphy.  
Statistical analysis: Dhvani Parikh 
 
Telomere aberrations were enumerated as telomere loss (signal free ends) or telomere 
doublets (fragile telomeres). (A) (Left) Representative images of telomere FISH of 
untreated (normal) and treated XPAC cells (5 J/m2 or 10 J/m2 UVC) (B) (Right) 
Representative images of telomere FISH of untreated (normal) and treated XP-A cells 
(5 J/m2 or 10 J/m2 UVC). Z-stacked images (0.25 μm steps) were acquired for each 
metaphase and analyzed. Average telomere defect per metaphase after 0, 5 or 10 J/m2 
UVC irradiation and 6 h recovery for both cell lines was plotted. Blue arrows indicate 
either telomere losses (signal free ends) or telomere doublets (multiple telomere signals 
per chromosome). Results are from 30 metaphases for each UV treatment in each cell 
line. The data represent mean ± SE from two individual experiments. Bars with * are 
significantly different (p<0.05, one-factor ANOVA, OriginPro 8 software). 
 
Figure 18: UVC induces telomere aberrations in XPAC and XP-A cells 
 
 
 
A.  B.  
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3.3.3 CPDs and 6-4 PPs are poorly removed from genomic DNA of XPAC cells 
We next wanted to test if the XPAC cells are proficient for NER. The reason for this was 
that although we did not observe a difference in UV-induced telomere aberrations 
between XPAC and XP-A cells, we did observe a difference in survival after UVC 
exposure between the two cell lines (see section 3.3.1) (Fig. 17A).  Furthermore, 
previous studies provided evidence that the XPAC cells express an adequate amount of 
XPA to perform repair [133].  Moreover our repair assays were standardized to detect 
reliably a lack of repair. Therefore, we performed repair assays on genomic DNA isolated 
from XPAC cells exposed to 10 J/m2 UVC using the immune spot blot assay as 
previously described for BJ-hTERT and XP-A cells in Chapter 2. We also performed Alu 
probing to confirm equal genomic DNA loading for all samples. 
 
We observed slow genomic CPD and 6-4 PP removal in XPAC cells when post UVC 
exposure of 10 J/m2 (Fig. 19).  This was quantified as 20% CPD repair and 50% 6-4 PP 
repair after 48 hours of UVC recovery. This was in stark contrast with our results for BJ-
hTERT cells which show 70% genomic CPD repair by 48 hours and nearly complete 
removal of genomic 6-4 PPs by 3 hours post UVC (see Chapter 2, section 2.5.2). XPAC 
cells also showed 5% genomic CPD repair and 30% genomic 6-4 PP repair by 12 hours 
post UVC (Fig. 19). We also observed that XP-A cells to exhibit lack removal of genomic 
6-4 PPs by 12 hours (see section 2.5.3). Therefore, XPAC cells removed UV 
photoproducts faster than XP-A cells, but much slower than immortalized BJ-hTERT 
cells.  This indicates that XPAC cells are proficient for NER but the repair rates are 
abnormally slow.  
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6-4 PP experiment courtesy: Elise Fouquerel 
 
(A) Cells were untreated or exposed to 10 J/m2 UVC followed by harvesting at various 
times (0-48 h). Genomic DNA for all repair time points was isolated and loaded in 
triplicate (7.5 ng). The blots were sequentially probed with a CPD antibody or 6-4 PP 
antibody as indicated, and then a radiolabeled Alu repeat DNA probe. (B) The CPD or 
6-4 PP signal intensity was quantitated, normalized to 0 hour and plotted against 
recovery time in the graph (right). Values are means and SE from two independent 
experiments. P-values are derived from one-factor ANOVA (see statistical analysis in 
methods). The difference between 6-4 PPs at 0 hour and 24 hour in XPAC cells is 
statistically significant (**p = 0.008). 
 
Figure 19: Quantification of CPD and 6-4 PP formation and removal in genomic 
DNA from UVC exposed XPAC cells 
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3.3.4 XPAC cells express abnormally high levels of XPA protein 
Since XPAC cells did not exhibit a difference in telomere aberrations and showed 
unusually slow repair of genomic DNA photoproducts by 48 hours (Figs. 18 and 19), 
western blotting analysis was performed to examine the level of XPA protein in the XPAC 
cell line compared to the BJ-hTERT and XP-A cell lines (Fig. 20). Protein lysates from 
each cell line were resolved by SDS-PAGE and then transferred to a membrane which 
was probed with an XPA antibody. The membrane was then stripped and tested for 
loading with the constitutively expressed protein glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH). We observed that the XPA protein levels appear to be several 
fold higher in XPAC cells compared to BJ-hTERT cells (Fig. 20).  We did not detect XPA 
protein in the XP-A cells. 
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XPA protein were analyzed in three cell lines for comparison: BJ-hTERT, XP-A and 
XPAC. Membranes were first probed with rabbit polyclonal XPA antibody and then 
stripped and re-probed with mouse monoclonal anti-GAPDH antibody for a loading 
control. 
  
Figure 20: Western blotting analysis of BJ-hTERT, XP-A and XPAC cells for the 
presence of XPA protein 
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3.3.5 Discussion 
In this study we set out to determine whether NER protects against UVC-induced 
telomere aberrations by comparing isogenic cells lines that differed in XPA protein 
expression, and thus, NER proficiency.  However, during the course of our study we 
discovered the surprising result that the XPA proficient cell lines exhibited abnormally 
slow NER.   
 
A previous study by Levy et al. in 1995 utilized the identical cell lines as in our study, 
XPA deficient (XP2OS or XP-A) and XPA complemented (XP2OS-pCAH19WS or XPAC) 
[133], to compare relative repair capacities post UVC damage in the two cell lines. For 
this, they transfected UVC damaged plasmids into the XP-A and XPAC cell lines, and 
after three days they observed that the XPAC cells showed improved transcriptional 
activity via enhanced expression of the plasmid reporter gene chloramphenicol acetyl 
transferase (CAT) [133] compared to XP-A cells. UV-induced photoproducts block CAT 
transcription and successful expression of the CAT gene requires removal of these UV 
photoproducts from the UV damaged plasmid. Removal of UV photoproducts would 
require a functional NER pathway with adequate XPA expression and thus, XPAC cells 
replete with XPA should be able to perform NER and thus lead to the CAT transcription. 
The observation that XPAC cells had a 100-fold higher CAT expression compared to XP-
A cells led to the conclusion by the authors that the XPAC cells were repairing the UVC 
damaged plasmid [133]. Furthermore, plasmids that were exposed to UVC (200 to 1000 
J/m2) and transfected into XP-A and XPAC, were poorly recovered from XP-A cells 
following two days of replication, compared to the XPAC cells [133]. Expression of XPA 
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in XPAC cells restored recovery of plasmid to up to 9% of the untreated control. The XP-
A cells in comparison showed only 0.01% plasmid recovery [133]. These represent 
indirect methods for assessing repair capacity, but support the conclusion that the XPAC 
cells are NER proficient. 
 
Our results agree with previous studies that the XPAC cells are NER proficient, but our 
results revealed abnormal rates of repair, while repair rates were not measured directly 
in the previous report.  In our studies we utilized a direct immuno-spot blot based assay 
to quantitate repair of CPDs and 6-4 PPs in genomic DNA of cells exposed to UVC as a 
function of time (see section 3.2.4). We observed that while XPAC cells were able to 
repair CPDs and 6-4 PPs, this rate of repair was lower than BJ-hTERT cells expressing 
wild type XPA protein (see Fig. 19 and Fig. 8, genomic DNA). Importantly, XPAC cells 
were able to remove CPDs and 6-4 PPs in genomic DNA as opposed to XP-A cells that 
lacked CPD and 6-4 PP repair (see Fig. 12, genomic DNA and Fig. 19). Furthermore, 
we observed that XPAC cells showed a 40% survival after 2 J/m2 UVC and 20% survival 
after 5 J/m2 UVC exposure as opposed to a rapid survival decline to 10% for XP-A cells 
for the same UVC doses (Fig. 17A). Based on these observations, it is reasonable to 
attribute the observed resistance of XPAC cells compared to XP-A, cells to the presence 
of XPA protein and NER activity.  
 
There could be a variety of reasons that the XPAC cells in our studies showed reduced 
rates of repair compared to the BJ-hTERT cells. We ruled the possibility that the XPAC 
cells were obtained lost XPA protein expression. In western blotting experiments we 
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confirmed that the XPAC cells retained XPA expression, whereas the XP-A cells lacked 
XPA expression. However, these experiments revealed that the XPAC cells possess 
much higher amounts of XPA protein as compared to wild type BJ-hTERT cells (Fig. 20). 
Thus, it is possible that excessive XPA protein expressed in the XPAC cells may be 
inhibiting the cellular NER mechanism by binding to and sequestering other repair factors 
downstream in the NER pathway. Since the XPAC cells are NER proficient, but just show 
slower repair, it is possible that sufficient repair of UV-damaged plasmids occurred in the 
two and three day time period for the plasmid transcription and replication assays to 
reach near normal levels of CAT transcription and plasmid recovery [133]. This may 
explain why Levy and colleagues did not detect a deficiency in repair capacity in the 
XPAC cells using these indirect assays [133].   Alternatively, it is also possible that XPAC 
gene may have undergone mutation in the cell line we obtained, leading to production of 
a non-functional XPA protein in the XPAC cells, perhaps due to reversion to the original 
XP-A cell line. Studies on various XPA complemented cell lines have reported a high 
frequency of reversion (5x10-5)  to the UV sensitivity phenotype of XP-A cell lines [150]. 
Re-sequencing analysis can be performed on XPAC cells to ascertain whether the XPA 
gene is mutated. 
 
In our Telo-FISH assay for scoring telomere aberrations, we observed that UVC induced 
a 2-fold increase in telomere losses in the XP-A and XPAC cell lines (Fig. 18). We 
expected to observe a lower number of UV-induced telomeres aberrations in the XPA 
expressing cells based on the prediction that the presence of NER would protect 
telomeres after UV exposure in XPAC cells.  However, we did not observe differences 
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between UV-induced telomere aberrations in XP-A compared to XPAC cells overall. We 
suspect that this is due to the abnormally slow rate of lesion removal in XPAC cells, such 
that significant lesions would have remained at the telomeres at the time of harvesting 
for telomere analysis.  Nevertheless, we were able to confirm that UVC exposure is 
damaging to telomeres in both cell lines. We observed that a UVC dose of 10 J/m2 in 
XP-A cells causes telomere losses to increase from 2.5 to 4.5 per metaphase (Fig. 18). 
These increases are observed in the complemented XPAC cell line as well, and are 
statistically significant compared to the untreated controls. In summary, we were unable 
to conclude from the XPAC cell lines we utilized that presence of NER protects telomeres 
from UVC-induced aberrations.  
 
In order to definitively determine if normal NER activity protects against UV-induced 
telomere aberrations we will need to repeat this study in isogenic wild type NER proficient 
and NER deficient cells lines.  For this, we propose to generate a cell line derived from 
wild type BJ-hTERT which are stably deficient in XPA protein by using small hairpin 
RNAs that specifically silence XPA expression (i.e. stable knockdown).  We will perform 
western blotting to confirm that the XPA protein is indeed greatly reduced in the XPA 
knock down cell line, and that this leads to increased cellular sensitivity to UVC exposure. 
If this is the case, then we expect that these cells would be deficient in NER capacity and 
consequently would show persistence of UV photoproducts at genomic and telomeric 
DNA during recovery time points in our immune-spot blot repair assay, indicating a lack 
of repair.  This pair of cell lines would be appropriate for addressing the question of 
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whether wild type NER activity reduces the levels of UVC-induced telomere losses and 
fragile telomeres, compared to NER deficient cells.   
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4 FINAL DISCUSSION 
4.1 SUMMARY OF FINDINGS 
Genomic stability is as important a life process for cellular survival as is metabolism. 
Since DNA damage from environmental and endogenous sources is inevitable, 
subsequent repair and restoration to undamaged DNA is essential. Prior to our study, it 
was known that ubiquitous ultraviolet (UV) light exposure generates the mutagenic DNA 
photoproduct CPD at telomeres [86, 87], but it was unknown if UV also generates 6-4 
PPs at telomeres and if the photoproducts are repaired at telomeres by the NER 
pathway. The purpose of this research was to investigate specifically if CPDs and 6-4 
PPs form at telomeres and if NER removes UV damage at telomeres (see section 1.3). 
We observed repair of UV-induced photoproducts from telomeres in the NER proficient 
cell lines BJ-hTERT and U2OS, and we failed to observe telomere repair in the NER 
deficient cell line XP-A (see section 2.5.2. and section 2.5.3). The importance of these 
findings was underscored by our discovery that a CPD lesion disrupted TRF1 binding to 
telomeric DNA in vitro, suggesting that UV photoproducts could disrupt shelterin integrity 
(see section 2.5.4).  
A previous study that measured telomeric CPD repair utilized an iPod 
(immunoprecipitation of damaged DNA) assay which is a polymerase chain reaction 
(PCR) based assay [86]. Briefly, primary lung fibroblasts were exposed to 10 J/m2 UVC 
or primary skin fibroblasts were exposed to 20 J/m2 UVC.  Genomic DNA was isolated,   
92 
sonicated and denatured, and the resulting ssDNA fragments containing CPDs were 
immunoprecipitated using an anti-CPD antibody [86]. The underlying principle of the 
assay was that the amount of UV-induced CPD damage within the cellular DNA should 
be proportional to the amount of DNA fragments immunoprecipitated using the CPD 
antibody. Finally, the DNA in the immunoprecipitated (IP’ed) fractions was amplified via 
quantitative PCR using primers specific for telomeric DNA, certain genes, or 
mitochondria DNA [86]. The resulting amplified products were visualized on an agarose 
gel and the signal intensities were quantified. The authors observed that the amount of 
amplified CPD-contained telomeric fractions from cells exposed to UVC did not vary with 
different recovery times from 0-48 hours [86]. However, the amount of amplified genomic 
p53 and 28S gene fractions decreased after 24 and 48 hours of repair time. The authors 
concluded that the decrease in IP’ed fraction was due to cellular CPD repair in the p53 
and 28S genes [86]. Additionally, they concluded that the observed lack of change in the 
amount of telomeric IP’ed fractions over 48 hours of repair time was because telomeres 
were refractory to CPD repair.  Their data implied that the amount of CPDs in all telomeric 
fractions isolated at different times remained the same. Thus, the study concluded that 
telomeres are refractory to CPD repair as opposed to our experiments that showed 
telomeric repair of both CPDs and 6-4 PPs by 48 hours [86]. 
Multiple reasons may account for the discrepant results that we observed compared to 
results obtained by Rochette and Brash regarding telomeric repair.  One potential 
explanation relates to the ability of telomeric DNA to form secondary structure. Both the 
damaged and undamaged DNA would have become single stranded in solution due to 
the denaturation step in the iPoD assay. The resulting ssDNA can form secondary 
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structures such as G quadruplexes in the G-rich repeats and i-Motif structures in the C-
rich repeats [151]. Since CPDs cause a distortion in the DNA, it is possible that the 
secondary structures in undamaged DNA, which also distort DNA, were recognized non-
specifically by the CPD antibodies.  This might explain why the authors obtained a 
relatively high telomeric signal intensity from untreated cells in the IP’d DNA, compared 
to the largely undetectable signals for the p53 and 28S genes recovered from untreated 
controls.  Alternatively, the CPD antibodies may not be able to access and bind to the 
CPDs in telomeric ssDNA fragments that were folded into secondary structure. Thus, it 
is possible that the CPD antibodies bound nonspecifically to secondary structures of 
undamaged DNA while failing to access the photoproducts within the damaged folded 
DNA, which would interfere with accurate quantification of CPD containing telomeric 
DNA [86]. Furthermore, a small portion of the damaged telomeric DNA that did not fold 
into secondary structures may have been accessible to the CPD antibodies and 
subsequently amplified via qPCR. Thus, it is possible that while the majority of the 
telomeres were being repaired in the cells, this small unrepaired fraction of the total 
telomeres was detected by the sensitive PCR assay but was beyond the limit of detection 
in our telomeric immuno-spot blot assay. We circumvented the problem of potential 
secondary structure formation in telomeric DNA in our assay, by denaturing telomeres 
in the nylon membrane and then fixing the telomeric DNA onto the membrane by baking 
at 80°C prior to immunoblotting. 
 
Another important difference between our study and that conducted by Rochette and 
Brash is the choice of cell lines used.  The primary fibroblasts used by Rochette and 
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Brash lack mechanisms to maintain telomere lengths. It is possible that the telomeric 
photoproduct removal that we observed in BJ-hTERT cells and U2OS cells may involve 
the telomere length maintenance mechanisms operating in these cells. BJ-hTERT cells 
express telomerase to maintain their telomeres while U2OS cells lack telomerase, but 
rather use the recombination-based alternative lengthening of telomeres (ALT) pathways 
to maintain telomeres. It is possible that telomeres undergoing length maintenance 
mechanisms are more accessible to repair proteins and perhaps ALT in U2OS cells 
might account for the slower rate of telomeric repair in U2OS cells than that observed 
for BJ-hTERT cells (see sections 2.5.3 and 2.5.3). This hypothesis is debatable because 
Kruk et al. reported in 1995 using telomere restriction fragment (TRF) analysis, that 
telomeric CPDs in normal primary fibroblasts (GM 38A, Coriell Cell Repository) are 
repaired at a rate similar to the CPD repair rate of non-transcribing genes [87]. The 
telomeric repair observed in these primary skin fibroblasts lacking telomere maintenance 
mechanisms would have occurred independently of ALT or telomerase. In order to 
determine whether telomeric photoproduct repair is indeed enabled or enhanced by 
telomere maintenance mechanisms, it would be necessary to measure both telomeric 
CPD and telomeric 6-4 PP repair rates in primary cells exposed to UVC using our direct 
telomeric immuno-blot assay.  
 
Cell lines from different tissues of origin may possess differences in telomeric repair 
capacities [152]. Interestingly, the study that concluded that telomeres lacked CPD repair 
[86] was performed in two different cell lines; a fibroblast cell line derived from lung tissue 
and exposed to 10 J/m2 UVC and a skin fibroblast cell line derived from breast tissue 
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and exposed to 20 J/m2 UVC. In contrast, our studies that support telomeric 
photoproduct repair were performed in a foreskin tissue derived fibroblast cell line 10 
J/m2 UVC. Comparison between the cell lines of similar tissue origin (skin fibroblasts) is 
difficult because the dose of UVC that was used to create damage was different. The 
higher dose of UVC used in the Rochette and Brash study (20 J/m2 instead of 10 J/m2) 
[86] may have caused a higher level of telomeric photoproducts. Perhaps at this higher 
level of damage, a fraction of telomeres may remain unrepaired at 48 hours. Thus, 
differences in both cell types and UVC dose may have contributed to differences in 
results from the study that concluded telomeres are refractory to repair [48] compared to 
our study in which we observed telomere repair. It would be valuable to compare 
telomeric repair rates using our direct telomeric immuno-blot assay in lung and skin 
primary fibroblasts both exposed to a minimally lethal dose of 10 J/m2 UVC.  
 
4.2 LIMITATIONS OF THE ASSAY 
A major limitation of our telomeric immune-spot blot assay is the requirement for copious 
amounts of purified genomic DNA as starting material. About 20x106 cells grown in 
eleven 100 mm dishes are needed to yield at least 100 ug of genomic DNA from which 
we obtained an average yield of 10-11 ng pure telomeric DNA for each repair time point. 
However, a significant advantage of our standardized assay is its inherent capability to 
directly identify and quantify varied types of telomeric damage such as oxidative base 
damage using sensitive antibodies that identify oxidative lesions such as 8-oxoguanines. 
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Also, environmental toxic bulky polycyclic aromatic hydrocarbon adducts and anti-tumor 
agent cisplatin adducts form in DNA but it is unknown if they occur at telomeres in vivo 
and if they are repaired. Our repair assay would thus be helpful in directly determining 
their formation and rate of removal using existing damage specific antibodies (Trevigen 
Anti-BPDE antibody for PAH adducts, Abcam Anti-Cisplatin modified DNA antibody for 
cisplatin adducts are currently available). 
4.3 FUTURE DIRECTIONS 
Of the six shelterin proteins, TRF1, TRF2 and POT1 directly bind to telomeric DNA while 
TPP1, TIN2 and RAP1 interact with those proteins, as opposed to binding DNA [7]. TRF1 
and TRF2 share a common TRFH domain and a C-terminal Myb domain that binds 
double stranded telomeric DNA, while POT1 binds to single stranded DNA through its N 
terminal OB folds [7]. It is possible that the binding inhibition we observed for TRF1 in 
the presence of a CPD lesion is limited to TRF1 alone and does not extend to other 
shelterin proteins. Therefore, it would be valuable to test TRF2 and POT1 binding as well 
to telomeric DNA substrates harboring a CPD lesion. We predict that CPD lesions will 
similarly inhibit TRF2 binding to dsDNA and POT1 binding to ssDNA in telomeres. 
 
To test the effect of CPD lesions on TRF1 and TRF2 binding to DNA in vivo, chromatin 
immunoprecipitation (ChIP) assays can be utilized. We expect that the yield of lesions in 
telomeres following an acute dose of UVC would be insufficient to displace a detectable 
amount of TRF1 or TRF2 proteins.  To circumvent this problem we would use plasmids 
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containing six telomeric repeats, as described previously [153], with defined lesions.  
Briefly, we would first transfect plasmids containing telomeric repeats into cells. These 
plasmids would be constructed using an oligonucleotide with a pre-synthesized site 
specific CPD lesion incorporated into the telomeric repeats [154]. As a control, plasmids 
constructed with templates lacking DNA lesions would be used. Post transfection of 
these plasmids into cells, TRF1 and TRF2 shelterin proteins inside the cells should bind 
to the telomeric repeats in these plasmids, as observed previously for other plasmids 
harboring telomeric repeats [155]. Next, we will test if the presence of CPD lesions within 
the telomeric repeats of the plasmids will affect TRF1 and TRF2 binding to the telomeric 
sequences. For this, we will perform ChIP using antibodies against TRF1 and TRF2 to 
immunoprecipitate (IP) cross-linked telomeric DNA-protein complexes. Sonication of 
cross-linked telomeric DNA-protein complexes prior to immunoprecipitation will create 
smaller sized fragments of plasmid DNA bound to TRF1/TRF2. After reverse cross 
linking of these complexes to remove associated TRF1/TRF2 proteins the telomeric DNA 
fragments can be identified and amplified via quantitative PCR. The qPCR assay would 
use primers that are complementary to the plasmid sequences flanking the telomeric 
DNA on both sides.  Therefore, only the telomeric repeats from the plasmid would be 
amplified and not the telomeric sequences at the chromosome ends. If CPD lesions 
indeed inhibited TRF1/TRF2 binding to telomeric DNA in cells, then we expect to recover 
lower yields of telomeric DNA in the TRF1/TRF2 immunoprecipated fractions from cells 
transfected with CPD contained plasmids, compared to non-lesion containing plasmids.  
Our observation that telomeric CPD repair was more rapid that CPD repair in the bulk 
genome raises the possibility that telomeric CPD repair was achieved by transcription 
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coupled repair (TCR).  This is because the bulk of the genome is repaired by global 
genome repair, which is slower than TCR.  The TCR pathway at telomeres is plausible 
because telomeres are actively transcribed into TERRA via action of transcription protein 
RNA polymerase II [85]. As described earlier, Cockayne syndrome A (CSA) and 
Cockayne syndrome B (CSB) are key proteins involved in TCR at the initial lesion 
recognition step in the pathway [156]. It is possible that disruption of these proteins may 
affect the repair rate we observe in telomeres. To test for this possibility, we will use a 
lentiviral system to generate stable knockdown of CSA or CSB protein levels in BJ-
hTERT cells via expression of small hairpin RNAs (shRNA) that target the CSA or CSB 
transcripts, respectively [157]. The shRNA will suppress expression of CSA or CSB, and 
cells expressing the antibiotic resistance gene in the vector will be selected by growth in 
media containing antibiotic. Since shRNAs can sometimes bind to and silence un-
intended transcripts or mRNA, causing off-target effects, four-five shRNAs having slightly 
different sequences will be tested instead of a single shRNA. Western blotting will be 
performed to confirm decrease protein levels of CSA/CSB in cells expressing the 
shRNAs. We will then expose these TCR deficient and the corresponding control cells 
to UVC, and perform the telomere repair assays as we described previously, to observe 
if there is a difference in the telomeric CPD repair rate in TCR deficient compared to TCR 
proficient cells (see section 2.5.2). Similar to CSA/CSB knockdown cell lines, we can 
also generate an XPC knockdown cell line via shRNAs against the XPC protein in BJ-
hTERT cells. XPC is required for global genome NER, but not for TCR [158]. This XPC 
knockdown cell line will serve as a negative control for telomeric TCR.  
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In summary, we expect to obtain the following results upon performing the telomeric 
repair experiments in TCR and GGR deficient cell lines. If TCR is functional at telomeres, 
we expect to observe a decrease in repair rates of telomeric CPDs in CSA/CSB deficient 
cell lines compared to CSA/CSB proficient cell lines exposed to UVC (see section 2.5.2). 
Conversely, if telomeres are repaired by TCR, and not GGR, then we do not expect to 
observe a difference in telomeric repair rates between XPC proficient and XPC deficient 
cell lines exposed to UVC.  
 
To confirm the lack of telomeric repair we observed in XP-A cells, an isogenic cell line to 
BJ-hTERT which lacks NER can be utilized. This BJ-hTERT XPA knockdown cell line 
can be generated by using shRNAs against XPA protein in BJ-hTERT cells similar to the 
CSA/CSB knockdown cells lines mentioned above. Telomeric repair experiments 
performed in these cells will allow for direct comparison between BJ-hTERT NER 
deficient and BJ-hTERT NER proficient cells. We expect that the BJ-hTERT XPA 
knockdown cells will show a lack of telomeric repair similar to what we observed in XP-
A cells (see section 2.5.3). 
 
The presence of NER at telomeres indicates that bulky lesions within shelterin coated 
telomeric DNA are accessible to NER proteins, suggesting that a dynamic interplay may 
occur between shelterin and NER proteins during repair. To test if shelterin proteins 
might modulate removal of CPD lesions on telomeric and non-telomeric substrates, we 
can perform in vitro NER assays using cell extracts in presence or absence of shelterin. 
For this, we will construct double stranded plasmids with telomeric and non-telomeric 
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sequences and place site-specific CPD lesion within the sequences using established 
protocols [159]. Naked substrates or substrates pre-coated with shelterin proteins will be 
incubated with cell extracts containing all the NER factors required for successful 
removal of the lesion. The excised lesions containing fragments released in the course 
of NER reactions can be visualized using radioactive end labeling, analyzed by 
denaturing gel electrophoresis and quantitated by phosphorimager scanning. If shelterin 
interaction with NER proteins promotes lesion removal at telomeres, then we expect to 
observe higher amounts of NER excision products for shelterin coated substrates than 
for naked substrates. 
4.4 BIOLOGICAL IMPLICATIONS  
Since NER is functional at telomeres, removal of photoproducts at telomeres is important 
for genome integrity. Accumulation of UV photoproducts has the potential to cause 
replication stress at telomeres, telomere shortening and telomere defects. Particularly, 
critically short telomeres can induce persistent DNA damage responses at telomeres 
which can trigger cell death or senescence in presence of tumor suppressor gene p53 
[19]. Pre-malignant cells lacking functional p53 and with short dysfunctional telomeres 
can override senescence causing genomic instability, which is a hallmark for cancer [23, 
160]. Unrepaired photoproducts at telomeres therefore, have the potential to drive 
senescence or cancer by causing telomere dysfunction in cells. In individuals whose skin 
may be chronically exposed to UV in sunlight, telomeric photoproducts can either be 
repaired or accumulate over time. NER capacities can differ among different individuals 
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[152] and in individuals with a lower telomeric NER capacity to remove UV 
photoproducts, an accumulation of telomeric photoproducts may cause telomere 
shortening or telomere dysfunction over a period of time. Short dysfunctional telomeres 
in turn can lead to accelerated senescence leading to skin aging or in a p53 deficient 
background, drive skin cancer. Thus, individuals who have a lower cellular NER capacity 
may have an increased susceptibility to UV-induced telomere shortening that can lead 
to UV driven skin aging or skin cancer. Knowledge about telomere repair in organisms 
can serve as an important biomarker for aging and disease. Levels of telomere repair in 
vivo can inform about mechanisms by which environmental toxicants such as UV in 
sunlight can function as gerontogens to accelerate skin aging or drive skin cancer [161]. 
Biomarkers of toxicology for aging and cancer that are not tissue specific (relate to 
several organs) and have a causal role in promoting aging or cancer have a need to be 
defined [161].  Our quantitative telomere repair assay that measures damage 
accumulation and repair capacities in different cells can serve as a valuable tool to 
develop biomarkers for decreased telomeric repair capacities in individuals and 
therefore, serve as an indicator of accelerated aging or pre-cancerous conditions. For 
example, we would expect that upon induction of UV photoproducts in the skin of 
individuals prone to accelerated aging or skin cancer, our repair assay would 
demonstrate persistence of damage at telomeres in cells of these individuals over time 
that would indicate a compromised DNA repair efficiency. We expect that if telomere 
lengths are measured from skin nevi biopsies of these individuals, the telomeres might 
be found to be shortened since cells with low NER capacity would be unable to fully 
prevent telomere shortening caused due to UV-induced replication stress. Our studies 
102 
will thus, aid in development of biomarkers for toxicology in skin photo-aging and skin 
cancer. 
4.5 STUDY CONCLUSIONS 
Our current study fills an important gap in existing knowledge about UV photoproduct 
formation and removal at telomeres. We show for the first time that 6-4 PPs are formed 
at telomeres after UV exposure and removed at rates comparable to bulk genomic DNA 
repair. Our findings open up a new area in basic science for investigation of the type of 
nucleotide excision repair pathway that might be active at telomeres. Going further, our 
study provides novel opportunities to investigate roles of dysfunctional telomeres in 
driving UV-induced carcinogenesis in a background of NER deficiency such as the 
xeroderma pigmentosum disorder.  
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APPENDIX: PRELIMINARY STUDY ON NER AND SHELTERIN INTERACTIONS 
SHELTERIN INHIBITS NER PROTEIN XPF-ERCC1 CLEAVAGE OF A STEM LOOP 
SUBSTRATE 
Introduction 
 
XPF-ERCC1 is a structure specific heterodimeric endonuclease that incises 5’ to the 
lesion in order to release the strand containing the bulky damage in the NER pathway 
(see section 1.2.5). XPF-ERCC1 localizes to telomeres and associates with the telomeric 
protein complex as shown by immunoprecipitation studies [92]. Previous cellular data 
indicates that XPF-ERCC1 cleaves the telomeric 3’ single strand overhang in the 
absence of TRF2 protein [92]. Moreover, residues that lie within the active site of XPF 
nuclease form part of a putative TRF2 docking motif that mediates protein interactions 
with TRF2 [162]. Transgenic mice that over express TRF2 in the skin exhibit increased 
susceptibility to UVB induced skin pathologies and cancer, similar to xeroderma 
pigmentosum, and telomere loss in skin cells, which was mediated by XPF-ERCC1 
endonuclease [93]. Thus, there is some evidence for interactions between XPF-ERCC1 
and shelterin protein TRF2, although whether TRF2 and XPF-ERCC1 can directly 
modulate each other’s activity has not been tested.  To examine this premise we 
conducted an activity assay for purified XPF-ERCC1 in presence of purified TRF2 protein 
in vitro. We observed a progressive decrease in XPF-ERCC1 activity on a stem loop 
substrate as a function of increasing TRF2 concentration. Our data provides preliminary 
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evidence to support the hypothesis that shelterin proteins interact with NER proteins to 
modulate their activity to preserve telomere integrity. 
 
Materials and Methods 
 
The stem–loop substrate (XPF SL) that was shown to be an optimal substrate for XPF-
ERCC1 cleavage was obtained from Orlando Scharer (Stony Brook University School of 
Medicine). XPF SL is a 46 base pair substrate with the sequence 
(GCCAGCGCTCGG(T)22CCGAGCGCTGGC) containing a “stem” and a “ loop” region 
in its structure. The 22 thymines (T’s) form the loop that mimics the bubble structure 
created around the DNA lesion during bulky lesion repair by the NER pathway. The rest 
of the 24 bases are paired into the stem structure (see model in Fig. 21). 10 pmol of the 
XPF SL substrate containing a fluorescent dye Cy5 as the 3’ end was annealed in a 200 
ul reaction buffer (10 mM Tris pH 8.0, 50 mM NaCl, 1 mM MgCl2) by initial heating at 
90oC for 10 minutes and cooling at room temperature for 2 hours, as previously 
described [163]. Purified recombinant human XPF-ERCC1 was generated from a 
baculovirus infected Sf9 insect cells using a histidine (His6) tag as previously described 
by Scharer lab [164] and was generously provided by Orlando Scharer.  Recombinant 
N-terminal His6-tagged TRF2 was purified using a baculovirus/insect cell expression 
system and an AKTA Explorer FPLC (GE Healthcare) as described previously [165]. 
Purified full length human TRF2 (400, 1600, or 3200 fmols) and XPF-ERCC1 
heterodimer (400 fmol) were pre-incubated in endonuclease buffer for 5 min at 30oC prior 
to addition of Cy5 3’ end labeled XPF SL substrate (100 fmol) to the reaction mix . The 
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endonuclease buffer consisted of 25 mM Tris pH 8.0, 40 mM NaCl, 0.5 mM  -
mercaptoethanol, 2 mM MgCl2, 0.5 mg/ml BSA and 10% glycerol in 15 l final reaction 
volume. The reactions were incubated at 37oC for 30 minutes and stopped via addition 
of 80% formamide/10 mM EDTA and heating at 95oC for 10 minutes. Reactions were 
electrophoresed on a 15% 19:1 (bisacrylamide:acrylamide) denaturing gel in 0.5X TBE 
buffer, visualized on Typhoon 9400 imaging system (Amersham Biosciences) and 
quantitated by ImageQuant software. 
 
Results 
 
XPF-ERCC1 incises at the 5’ side of the stem loop substrate (S) releasing a 9-10 
basepair fragment that is represented in the gel as P (product). In our experiments, XPF-
ERCC1 exhibited a maximum cleavage of about 15% of the stem loop substrate in the 
absence of TRF2. This incision activity reduces to below detectable levels in presence 
of a 4 fold molar ratio of TRF2 homodimer to XPF ERCC1 heterodimer. 
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Reactions contained a Cy5-labeled stem-loop substrate and 400 fmol XPF-ERCC1. 
Number = molar ratio of TRF2 homodimer to XPF-ERCC1 heterodimer. S=substrate and 
P=product. Reactions were run on 14% denaturing gel. Values and error bars are the 
mean and SE from 3 independent experiments. 
 
Figure 21: Inhibition of XPF-ERCC1 activity on stem-loop substrate by TRF2 
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Discussion and conclusion  
 
A previous publication reported that XPF is required for TRF2 mediated telomere 
shortening and that XPF controls both TRF2 and telomere length as a negative regulator 
[166]. When wild type XPF was introduced into XPF-deficient cells, TRF2 association 
with telomeric DNA decreased by 40%. Moreover, XPF when overexpressed in XPF-
proficient cells induced telomere shortening [166]. XPF- ERCC1 also was shown to 
associate with TRF2 at telomeres, and to remove the 3’ overhang from uncapped 
telomeres [92]. Whether the interaction between TRF2 and XPF-ERCC1 is direct, or is 
mediated by another protein, is not known.  This is the first study to provide preliminary 
evidence for functional interactions between TRF2 and XPF-ERCC1 and its possible 
effect on the activity of XPF-ERCC1. Using a telomeric substrate to test this interaction 
might further shed light on the dynamics between NER and shelterin proteins at 
telomeres, however, it is possible that TRF2 and XPF-ERCC1 may interact directly at 
sites distal from the telomeres too. 
 
 
 
108 
BIBLIOGRAPHY 
1. Gall, J.G., Telomeres. 1995, Cold Spring Harbor, New York: Cold Spring Harbor 
Press. 
2. Szostak, J.W. and E.H. Blackburn, Cloning yeast telomeres on linear plasmid 
vectors. Cell, 1982. 29(1): p. 245-55. 
3. Olovnikov, A.M., [Principle of marginotomy in template synthesis of 
polynucleotides]. Dokl Akad Nauk SSSR, 1971. 201(6): p. 1496-9. 
4. Zakian, V.A., Telomeres: beginning to understand the end. Science, 1995. 
270(5242): p. 1601-7. 
5. Blackburn, E.H., et al., Recognition and elongation of telomeres by telomerase. 
Genome, 1989. 31(2): p. 553-60. 
6. Greider, C.W. and E.H. Blackburn, A telomeric sequence in the RNA of 
Tetrahymena telomerase required for telomere repeat synthesis. Nature, 1989. 
337(6205): p. 331-7. 
7. de Lange, T., Shelterin: the protein complex that shapes and safeguards human 
telomeres. Genes Dev, 2005. 19(18): p. 2100-10. 
8. Griffith, J.D., et al., Mammalian telomeres end in a large duplex loop. Cell, 1999. 
97(4): p. 503-14. 
9. Palm, W. and T. de Lange, How shelterin protects mammalian telomeres. Annu 
Rev Genet, 2008. 42: p. 301-34. 
10. Doksani, Y., et al., Super-resolution fluorescence imaging of telomeres reveals 
TRF2-dependent T-loop formation. Cell, 2013. 155(2): p. 345-56. 
11. Sfeir, A., et al., Mammalian telomeres resemble fragile sites and require TRF1 for 
efficient replication. Cell, 2009. 138(1): p. 90-103. 
12. Denchi, E.L. and T. de Lange, Protection of telomeres through independent 
control of ATM and ATR by TRF2 and POT1. Nature, 2007. 448(7157): p. 1068-
71. 
13. Sfeir, A. and T. de Lange, Removal of shelterin reveals the telomere end-
protection problem. Science, 2012. 336(6081): p. 593-7. 
14. Bae, N.S. and P. Baumann, A RAP1/TRF2 complex inhibits nonhomologous end-
joining at human telomeric DNA ends. Mol Cell, 2007. 26(3): p. 323-34. 
15. Wu, L., et al., Pot1 deficiency initiates DNA damage checkpoint activation and 
aberrant homologous recombination at telomeres. Cell, 2006. 126(1): p. 49-62. 
16. Sfeir, A., et al., Loss of Rap1 induces telomere recombination in the absence of 
NHEJ or a DNA damage signal. Science, 2010. 327(5973): p. 1657-61. 
17. van Steensel, B., A. Smogorzewska, and T. de Lange, TRF2 protects human 
telomeres from end-to-end fusions. Cell, 1998. 92(3): p. 401-13. 
18. Nandakumar, J., E.R. Podell, and T.R. Cech, How telomeric protein POT1 avoids 
RNA to achieve specificity for single-stranded DNA. Proc Natl Acad Sci U S A, 
2010. 107(2): p. 651-6. 
19. d'Adda di Fagagna, F., et al., A DNA damage checkpoint response in telomere-
initiated senescence. Nature, 2003. 426(6963): p. 194-8. 
109 
20. Jeyapalan, J.C. and J.M. Sedivy, Cellular senescence and organismal aging. 
Mech Ageing Dev, 2008. 129(7-8): p. 467-74. 
21. Hemann, M.T., et al., The shortest telomere, not average telomere length, is 
critical for cell viability and chromosome stability. Cell, 2001. 107(1): p. 67-77. 
22. Kaul, Z., et al., Five dysfunctional telomeres predict onset of senescence in 
human cells. EMBO Rep, 2012. 13(1): p. 52-9. 
23. Hanahan, D. and R.A. Weinberg, Hallmarks of cancer: the next generation. Cell, 
2011. 144(5): p. 646-74. 
24. Lopez-Otin, C., et al., The hallmarks of aging. Cell, 2013. 153(6): p. 1194-217. 
25. de Lange, T., Activation of telomerase in a human tumor. Proc Natl Acad Sci U S 
A, 1994. 91(8): p. 2882-5. 
26. Cesare, A.J. and R.R. Reddel, Alternative lengthening of telomeres: models, 
mechanisms and implications. Nat Rev Genet, 2010. 11(5): p. 319-30. 
27. De Bont, R. and N. van Larebeke, Endogenous DNA damage in humans: a review 
of quantitative data. Mutagenesis, 2004. 19(3): p. 169-85. 
28. Friedberg, E.C., G.C. Walker, and W. Siede, DNA repair and mutagenesis. 1995, 
Washington, D.C.: ASM Press. xvii, 698 p., 8 p. of plates. 
29. International Agency for Research on Cancer., Exposure to artificial UV radiation 
and skin cancer : this report represents the views and expert opinions of an IARC 
working group that met in Lyon, France 27-29 June 2005. IARC working group 
reports. 2005, Lyon, France: International Agency for Research on Cancer. p. 
30. Thornhill, M.H., The sun, the ozone layer and the skin: the role of ultraviolet light 
in lip and skin cancer. Dent Update, 1993. 20(6): p. 236-40. 
31. Taylor, H.R., et al., Effect of ultraviolet radiation on cataract formation. N Engl J 
Med, 1988. 319(22): p. 1429-33. 
32. Diffey, B.L., Stratospheric ozone depletion and the risk of non-melanoma skin 
cancer in a British population. Phys Med Biol, 1992. 37(12): p. 2267-79. 
33. Besaratinia, A., S.I. Kim, and G.P. Pfeifer, Rapid repair of UVA-induced oxidized 
purines and persistence of UVB-induced dipyrimidine lesions determine the 
mutagenicity of sunlight in mouse cells. FASEB J, 2008. 22(7): p. 2379-92. 
34. Shibutani, S., M. Takeshita, and A.P. Grollman, Insertion of specific bases during 
DNA synthesis past the oxidation-damaged base 8-oxodG. Nature, 1991. 
349(6308): p. 431-4. 
35. Michaels, M.L., et al., Evidence that MutY and MutM combine to prevent 
mutations by an oxidatively damaged form of guanine in DNA. Proc Natl Acad Sci 
U S A, 1992. 89(15): p. 7022-5. 
36. Matsumoto, Y. and K. Kim, Excision of deoxyribose phosphate residues by DNA 
polymerase beta during DNA repair. Science, 1995. 269(5224): p. 699-702. 
37. Friedberg, E.C. and E.C. Friedberg, DNA repair and mutagenesis. 2nd ed. 2006, 
Washington, D.C.: ASM Press. xxix, 1118 p. 
38. Kurz, D.J., et al., Chronic oxidative stress compromises telomere integrity and 
accelerates the onset of senescence in human endothelial cells. J Cell Sci, 2004. 
117(Pt 11): p. 2417-26. 
39. Opresko, P.L., et al., Oxidative damage in telomeric DNA disrupts recognition by 
TRF1 and TRF2. Nucleic Acids Res, 2005. 33(4): p. 1230-9. 
110 
40. Wang, Z., et al., Characterization of oxidative guanine damage and repair in 
mammalian telomeres. PLoS Genet, 2010. 6(5): p. e1000951. 
41. Vallabhaneni, H., et al., Defective repair of oxidative base lesions by the DNA 
glycosylase Nth1 associates with multiple telomere defects. PLoS Genet, 2013. 
9(7): p. e1003639. 
42. Madlener, S., et al., Essential role for mammalian apurinic/apyrimidinic (AP) 
endonuclease Ape1/Ref-1 in telomere maintenance. Proc Natl Acad Sci U S A, 
2013. 110(44): p. 17844-9. 
43. Setlow, R.B., The photochemistry, photobiology, and repair of polynucleotides. 
Prog Nucleic Acid Res Mol Biol, 1968. 8: p. 257-95. 
44. Wacker, A., et al., ORGANIC PHOTOCHEMISTRY OF NUCLEIC ACIDS*. 
Photochemistry and Photobiology, 1964. 3(4): p. 369-394. 
45. Mitchell, D.L., J. Jen, and J.E. Cleaver, Sequence specificity of cyclobutane 
pyrimidine dimers in DNA treated with solar (ultraviolet B) radiation. Nucleic Acids 
Res, 1992. 20(2): p. 225-9. 
46. Kim, J.K., D. Patel, and B.S. Choi, Contrasting structural impacts induced by cis-
syn cyclobutane dimer and (6-4) adduct in DNA duplex decamers: implication in 
mutagenesis and repair activity. Photochem Photobiol, 1995. 62(1): p. 44-50. 
47. Mizukoshi, T., et al., Structural study of DNA duplexes containing the (6-4) 
photoproduct by fluorescence resonance energy transfer. Nucleic Acids Res, 
2001. 29(24): p. 4948-54. 
48. Brash, D.E., et al., Photoproduct frequency is not the major determinant of UV 
base substitution hot spots or cold spots in human cells. Proc Natl Acad Sci U S 
A, 1987. 84(11): p. 3782-6. 
49. Mitchell, D.L. and R.S. Nairn, The biology of the (6-4) photoproduct. Photochem 
Photobiol, 1989. 49(6): p. 805-19. 
50. Perdiz, D., et al., Distribution and repair of bipyrimidine photoproducts in solar UV-
irradiated mammalian cells. Possible role of Dewar photoproducts in solar 
mutagenesis. J Biol Chem, 2000. 275(35): p. 26732-42. 
51. Todo, T., Functional diversity of the DNA photolyase/blue light receptor family. 
Mutat Res, 1999. 434(2): p. 89-97. 
52. Lemaire, D.G. and B.P. Ruzsicska, Kinetic analysis of the deamination reactions 
of cyclobutane dimers of thymidylyl-3',5'-2'-deoxycytidine and 2'-deoxycytidylyl-
3',5'-thymidine. Biochemistry, 1993. 32(10): p. 2525-33. 
53. Douki, T. and J. Cadet, Formation of cyclobutane dimers and (6-4) photoproducts 
upon far-UV photolysis of 5-methylcytosine-containing dinucleotide 
monophosphates. Biochemistry, 1994. 33(39): p. 11942-50. 
54. Tommasi, S., M.F. Denissenko, and G.P. Pfeifer, Sunlight induces pyrimidine 
dimers preferentially at 5-methylcytosine bases. Cancer Res, 1997. 57(21): p. 
4727-30. 
55. Tsaalbi-Shtylik, A., et al., Persistently stalled replication forks inhibit nucleotide 
excision repair in trans by sequestering Replication protein A. Nucleic Acids Res, 
2014. 42(7): p. 4406-13. 
56. Andersen, P.L., et al., Sequential assembly of translesion DNA polymerases at 
UV-induced DNA damage sites. Mol Biol Cell, 2011. 22(13): p. 2373-83. 
111 
57. Wang, Y.C., V.M. Maher, and J.J. McCormick, Xeroderma pigmentosum variant 
cells are less likely than normal cells to incorporate dAMP opposite photoproducts 
during replication of UV-irradiated plasmids. Proc Natl Acad Sci U S A, 1991. 
88(17): p. 7810-4. 
58. Protic-Sabljic, M., et al., UV light-induced cyclobutane pyrimidine dimers are 
mutagenic in mammalian cells. Mol Cell Biol, 1986. 6(10): p. 3349-56. 
59. Glazer, P.M., S.N. Sarkar, and W.C. Summers, Detection and analysis of UV-
induced mutations in mammalian cell DNA using a lambda phage shuttle vector. 
Proc Natl Acad Sci U S A, 1986. 83(4): p. 1041-4. 
60. Mouret, S., et al., Cyclobutane pyrimidine dimers are predominant DNA lesions in 
whole human skin exposed to UVA radiation. Proc Natl Acad Sci U S A, 2006. 
103(37): p. 13765-70. 
61. Husain, I., J. Griffith, and A. Sancar, Thymine dimers bend DNA. Proc Natl Acad 
Sci U S A, 1988. 85(8): p. 2558-62. 
62. Park, H., et al., Crystal structure of a DNA decamer containing a cis-syn thymine 
dimer. Proc Natl Acad Sci U S A, 2002. 99(25): p. 15965-70. 
63. Mitchell, D.L., The relative cytotoxicity of (6-4) photoproducts and cyclobutane 
dimers in mammalian cells. Photochem Photobiol, 1988. 48(1): p. 51-7. 
64. Kantor, G.J. and R.B. Setlow, Rate and extent of DNA repair in nondividing human 
diploid fibroblasts. Cancer Res, 1981. 41(3): p. 819-25. 
65. Mitchell, D.L., et al., Loss of thymine dimers from mammalian cell DNA. The 
kinetics for antibody-binding sites are not the same as that for T4 endonuclease 
V sites. Biochim Biophys Acta, 1982. 697(3): p. 270-7. 
66. Williams, J.I. and J.E. Cleaver, Removal of T4 endonuclease V-sensitive sites 
from SV40 DNA after exposure to ultraviolet light. Biochim Biophys Acta, 1979. 
562(3): p. 429-37. 
67. Fousteri, M., et al., Cockayne syndrome A and B proteins differentially regulate 
recruitment of chromatin remodeling and repair factors to stalled RNA polymerase 
II in vivo. Mol Cell, 2006. 23(4): p. 471-82. 
68. Groisman, R., et al., CSA-dependent degradation of CSB by the ubiquitin-
proteasome pathway establishes a link between complementation factors of the 
Cockayne syndrome. Genes Dev, 2006. 20(11): p. 1429-34. 
69. Scrima, A., et al., Structural basis of UV DNA-damage recognition by the DDB1-
DDB2 complex. Cell, 2008. 135(7): p. 1213-23. 
70. Coin, F., V. Oksenych, and J.M. Egly, Distinct roles for the XPB/p52 and XPD/p44 
subcomplexes of TFIIH in damaged DNA opening during nucleotide excision 
repair. Mol Cell, 2007. 26(2): p. 245-56. 
71. Winkler, G.S., et al., TFIIH with inactive XPD helicase functions in transcription 
initiation but is defective in DNA repair. J Biol Chem, 2000. 275(6): p. 4258-66. 
72. Fuss, J.O. and J.A. Tainer, XPB and XPD helicases in TFIIH orchestrate DNA 
duplex opening and damage verification to coordinate repair with transcription and 
cell cycle via CAK kinase. DNA Repair (Amst), 2011. 10(7): p. 697-713. 
73. Zotter, A., et al., Recruitment of the nucleotide excision repair endonuclease XPG 
to sites of UV-induced dna damage depends on functional TFIIH. Mol Cell Biol, 
2006. 26(23): p. 8868-79. 
112 
74. Overmeer, R.M., et al., Replication protein A safeguards genome integrity by 
controlling NER incision events. J Cell Biol, 2011. 192(3): p. 401-15. 
75. Marteijn, J.A., et al., Understanding nucleotide excision repair and its roles in 
cancer and ageing. Nat Rev Mol Cell Biol, 2014. 15(7): p. 465-81. 
76. Shivji, M.K., et al., Dual-incision assays for nucleotide excision repair using DNA 
with a lesion at a specific site. Methods Mol Biol, 1999. 113: p. 373-92. 
77. Ogi, T., et al., Three DNA polymerases, recruited by different mechanisms, carry 
out NER repair synthesis in human cells. Mol Cell, 2010. 37(5): p. 714-27. 
78. Moser, J., et al., Sealing of chromosomal DNA nicks during nucleotide excision 
repair requires XRCC1 and DNA ligase III alpha in a cell-cycle-specific manner. 
Mol Cell, 2007. 27(2): p. 311-23. 
79. DiGiovanna, J.J. and K.H. Kraemer, Shining a light on xeroderma pigmentosum. 
J Invest Dermatol, 2012. 132(3 Pt 2): p. 785-96. 
80. Bradford, P.T., et al., Cancer and neurologic degeneration in xeroderma 
pigmentosum: long term follow-up characterises the role of DNA repair. J Med 
Genet, 2011. 48(3): p. 168-76. 
81. Kleijer, W.J., et al., Incidence of DNA repair deficiency disorders in western 
Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. 
DNA Repair (Amst), 2008. 7(5): p. 744-50. 
82. Wang, Y., et al., Dysregulation of gene expression as a cause of Cockayne 
syndrome neurological disease. Proc Natl Acad Sci U S A, 2014. 111(40): p. 
14454-9. 
83. Rapin, I., et al., Cockayne syndrome in adults: review with clinical and pathologic 
study of a new case. J Child Neurol, 2006. 21(11): p. 991-1006. 
84. Sarthy, J.F. and P. Baumann, Apollo-taking the lead in telomere protection. Mol 
Cell, 2010. 39(4): p. 489-91. 
85. Azzalin, C.M., et al., Telomeric repeat containing RNA and RNA surveillance 
factors at mammalian chromosome ends. Science, 2007. 318(5851): p. 798-801. 
86. Rochette, P.J. and D.E. Brash, Human telomeres are hypersensitive to UV-
induced DNA Damage and refractory to repair. PLoS Genet, 2010. 6(4): p. 
e1000926. 
87. Kruk, P.A., N.J. Rampino, and V.A. Bohr, DNA damage and repair in telomeres: 
relation to aging. Proc Natl Acad Sci U S A, 1995. 92(1): p. 258-62. 
88. Sugasawa, K., et al., Xeroderma pigmentosum group C protein complex is the 
initiator of global genome nucleotide excision repair. Mol Cell, 1998. 2(2): p. 223-
32. 
89. Stout, G.J. and M.A. Blasco, Telomere length and telomerase activity impact the 
UV sensitivity syndrome xeroderma pigmentosum C. Cancer Res, 2013. 73(6): p. 
1844-54. 
90. Kassam, S.N. and A.J. Rainbow, Deficient base excision repair of oxidative DNA 
damage induced by methylene blue plus visible light in xeroderma pigmentosum 
group C fibroblasts. Biochem Biophys Res Commun, 2007. 359(4): p. 1004-9. 
91. D'Errico, M., et al., New functions of XPC in the protection of human skin cells 
from oxidative damage. EMBO J, 2006. 25(18): p. 4305-15. 
113 
92. Zhu, X.D., et al., ERCC1/XPF removes the 3' overhang from uncapped telomeres 
and represses formation of telomeric DNA-containing double minute 
chromosomes. Mol Cell, 2003. 12(6): p. 1489-98. 
93. Munoz, P., et al., XPF nuclease-dependent telomere loss and increased DNA 
damage in mice overexpressing TRF2 result in premature aging and cancer. Nat 
Genet, 2005. 37(10): p. 1063-71. 
94. Fumagalli, M., et al., Telomeric DNA damage is irreparable and causes persistent 
DNA-damage-response activation. Nat Cell Biol, 2012. 14(4): p. 355-65. 
95. Bohr, V.A., et al., DNA repair in an active gene: removal of pyrimidine dimers from 
the DHFR gene of CHO cells is much more efficient than in the genome overall. 
Cell, 1985. 40(2): p. 359-69. 
96. Maicher, A., et al., Deregulated telomere transcription causes replication-
dependent telomere shortening and promotes cellular senescence. Nucleic Acids 
Res, 2012. 40(14): p. 6649-59. 
97. Hess, M.T., et al., Base pair conformation-dependent excision of benzo[a]pyrene 
diol epoxide-guanine adducts by human nucleotide excision repair enzymes. Mol 
Cell Biol, 1997. 17(12): p. 7069-76. 
98. Braithwaite, E., X. Wu, and Z. Wang, Repair of DNA lesions induced by polycyclic 
aromatic hydrocarbons in human cell-free extracts: involvement of two excision 
repair mechanisms in vitro. Carcinogenesis, 1998. 19(7): p. 1239-46. 
99. Jain, V., et al., Conformational and thermodynamic properties modulate the 
nucleotide excision repair of 2-aminofluorene and 2-acetylaminofluorene dG 
adducts in the NarI sequence. Nucleic Acids Res, 2012. 40(9): p. 3939-51. 
100. Lukin, M., et al., Structure and stability of DNA containing an aristolactam II-dA 
lesion: implications for the NER recognition of bulky adducts. Nucleic Acids Res, 
2012. 40(6): p. 2759-70. 
101. Alekseyev, Y.O., M.L. Hamm, and J.M. Essigmann, Aflatoxin B1 
formamidopyrimidine adducts are preferentially repaired by the nucleotide 
excision repair pathway in vivo. Carcinogenesis, 2004. 25(6): p. 1045-51. 
102. O'Brien, T.J., B.R. Brooks, and S.R. Patierno, Nucleotide excision repair functions 
in the removal of chromium-induced DNA damage in mammalian cells. Mol Cell 
Biochem, 2005. 279(1-2): p. 85-95. 
103. Furuta, T., et al., Transcription-coupled nucleotide excision repair as a 
determinant of cisplatin sensitivity of human cells. Cancer Res, 2002. 62(17): p. 
4899-902. 
104. Ikeda, H., et al., Quantitative fluorescence in situ hybridization measurement of 
telomere length in skin with/without sun exposure or actinic keratosis. Hum 
Pathol, 2014. 45(3): p. 473-80. 
105. Farmer, H., et al., Targeting the DNA repair defect in BRCA mutant cells as a 
therapeutic strategy. Nature, 2005. 434(7035): p. 917-21. 
106. Helleday, T., et al., DNA repair pathways as targets for cancer therapy. Nat Rev 
Cancer, 2008. 8(3): p. 193-204. 
107. Hoeijmakers, J.H., DNA damage, aging, and cancer. N Engl J Med, 2009. 
361(15): p. 1475-85. 
114 
108. Szymkowski, D.E., C.W. Lawrence, and R.D. Wood, Repair by human cell 
extracts of single (6-4) and cyclobutane thymine-thymine photoproducts in DNA. 
Proc Natl Acad Sci U S A, 1993. 90(21): p. 9823-7. 
109. Yoon, J.H., et al., The DNA damage spectrum produced by simulated sunlight. J 
Mol Biol, 2000. 299(3): p. 681-93. 
110. Garinis, G.A., et al., Transcriptome analysis reveals cyclobutane pyrimidine 
dimers as a major source of UV-induced DNA breaks. EMBO J, 2005. 24(22): p. 
3952-62. 
111. Lange, S.S., K. Takata, and R.D. Wood, DNA polymerases and cancer. Nat Rev 
Cancer, 2011. 11(2): p. 96-110. 
112. Hanawalt, P.C. and G. Spivak, Transcription-coupled DNA repair: two decades of 
progress and surprises. Nat Rev Mol Cell Biol, 2008. 9(12): p. 958-70. 
113. Gillet, L.C. and O.D. Scharer, Molecular mechanisms of mammalian global 
genome nucleotide excision repair. Chem Rev, 2006. 106(2): p. 253-76. 
114. Masutani, C., et al., The XPV (xeroderma pigmentosum variant) gene encodes 
human DNA polymerase eta. Nature, 1999. 399(6737): p. 700-4. 
115. Armanios, M. and E.H. Blackburn, The telomere syndromes. Nat Rev Genet, 
2012. 
116. Finkel, T., M. Serrano, and M.A. Blasco, The common biology of cancer and 
ageing. Nature, 2007. 448(7155): p. 767-74. 
117. Wright, W.E. and J.W. Shay, Telomere biology in aging and cancer. J Am Geriatr 
Soc, 2005. 53(9 Suppl): p. S292-4. 
118. Emanuele, E., et al., Topical application of preparations containing DNA repair 
enzymes prevents ultraviolet-induced telomere shortening and c-FOS proto-
oncogene hyperexpression in human skin: an experimental pilot study. J Drugs 
Dermatol, 2013. 12(9): p. 1017-21. 
119. Wright, W.E., et al., Normal human chromosomes have long G-rich telomeric 
overhangs at one end. Genes Dev, 1997. 11(21): p. 2801-9. 
120. de Lange, T., Telomere biology and DNA repair: enemies with benefits. FEBS 
Lett, 2010. 584(17): p. 3673-4. 
121. Opresko, P.L., et al., The Werner syndrome helicase and exonuclease cooperate 
to resolve telomeric D loops in a manner regulated by TRF1 and TRF2. Mol Cell, 
2004. 14(6): p. 763-74. 
122. Herbert, B.S., J.W. Shay, and W.E. Wright, Analysis of telomeres and telomerase. 
Curr Protoc Cell Biol, 2003. Chapter 18: p. Unit 18 6. 
123. Kimura, M., et al., Measurement of telomere length by the Southern blot analysis 
of terminal restriction fragment lengths. Nat Protoc, 2010. 5(9): p. 1596-607. 
124. Wani, A.A., S.M. D'Ambrosio, and N.K. Alvi, Quantitation of pyrimidine dimers by 
immunoslot blot following sublethal UV-irradiation of human cells. Photochem 
Photobiol, 1987. 46(4): p. 477-82. 
125. Ayala-Torres, S., et al., Analysis of gene-specific DNA damage and repair using 
quantitative polymerase chain reaction. Methods, 2000. 22(2): p. 135-47. 
126. Kad, N.M., et al., Collaborative dynamic DNA scanning by nucleotide excision 
repair proteins investigated by single- molecule imaging of quantum-dot-labeled 
proteins. Mol Cell, 2010. 37(5): p. 702-13. 
115 
127. Bodnar, A.G., et al., Extension of life-span by introduction of telomerase into 
normal human cells. Science, 1998. 279(5349): p. 349-52. 
128. Batzer, M.A. and P.L. Deininger, Alu repeats and human genomic diversity. Nat 
Rev Genet, 2002. 3(5): p. 370-9. 
129. Grolimund, L., et al., A quantitative telomeric chromatin isolation protocol 
identifies different telomeric states. Nat Commun, 2013. 4: p. 2848. 
130. Heffernan, T.P., et al., An ATR- and Chk1-dependent S checkpoint inhibits 
replicon initiation following UVC-induced DNA damage. Mol Cell Biol, 2002. 
22(24): p. 8552-61. 
131. Mitchell, D.L., C.A. Haipek, and J.M. Clarkson, (6-4)Photoproducts are removed 
from the DNA of UV-irradiated mammalian cells more efficiently than cyclobutane 
pyrimidine dimers. Mutat Res, 1985. 143(3): p. 109-12. 
132. Vreeswijk, M.P., et al., Analysis of repair of cyclobutane pyrimidine dimers and 
pyrimidine 6-4 pyrimidone photoproducts in transcriptionally active and inactive 
genes in Chinese hamster cells. J Biol Chem, 1994. 269(50): p. 31858-63. 
133. Levy, D.D., et al., Expression of a transfected DNA repair gene (XPA) in 
xeroderma pigmentosum group A cells restores normal DNA repair and 
mutagenesis of UV-treated plasmids. Carcinogenesis, 1995. 16(7): p. 1557-63. 
134. Herbert, B.S., et al., A peroxisome proliferator-activated receptor-gamma agonist 
and the p53 rescue drug CP-31398 inhibit the spontaneous immortalization of 
breast epithelial cells. Cancer Res, 2003. 63(8): p. 1914-9. 
135. Tornaletti, S. and G.P. Pfeifer, UV light as a footprinting agent: modulation of UV-
induced DNA damage by transcription factors bound at the promoters of three 
human genes. J Mol Biol, 1995. 249(4): p. 714-28. 
136. Ford, J.M. and P.C. Hanawalt, Expression of wild-type p53 is required for efficient 
global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J 
Biol Chem, 1997. 272(44): p. 28073-80. 
137. Luke, B. and J. Lingner, TERRA: telomeric repeat-containing RNA. EMBO J, 
2009. 28(17): p. 2503-10. 
138. van Hoffen, A., et al., Transcription-coupled repair removes both cyclobutane 
pyrimidine dimers and 6-4 photoproducts with equal efficiency and in a sequential 
way from transcribed DNA in xeroderma pigmentosum group C fibroblasts. EMBO 
J, 1995. 14(2): p. 360-7. 
139. Steinert, S., J.W. Shay, and W.E. Wright, Modification of subtelomeric DNA. Mol 
Cell Biol, 2004. 24(10): p. 4571-80. 
140. Courdavault, S., et al., Repair of the three main types of bipyrimidine DNA 
photoproducts in human keratinocytes exposed to UVB and UVA radiations. DNA 
Repair (Amst), 2005. 4(7): p. 836-44. 
141. Bryan, T.M. and P. Baumann, G-quadruplexes: from guanine gels to 
chemotherapeutics. Mol Biotechnol, 2011. 49(2): p. 198-208. 
142. Pope-Varsalona, H., et al., Polymerase eta suppresses telomere defects induced 
by DNA damaging agents. Nucleic Acids Res, 2014. 
143. de Vries, A., et al., Increased susceptibility to ultraviolet-B and carcinogens of 
mice lacking the DNA excision repair gene XPA. Nature, 1995. 377(6545): p. 169-
73. 
116 
144. Tsodikov, O.V., et al., Structural basis for the recruitment of ERCC1-XPF to 
nucleotide excision repair complexes by XPA. EMBO J, 2007. 26(22): p. 4768-76. 
145. Miyauchi-Hashimoto, H., K. Tanaka, and T. Horio, Enhanced inflammation and 
immunosuppression by ultraviolet radiation in xeroderma pigmentosum group A 
(XPA) model mice. J Invest Dermatol, 1996. 107(3): p. 343-8. 
146. Liu, F.J., A. Barchowsky, and P.L. Opresko, The Werner syndrome protein 
suppresses telomeric instability caused by chromium (VI) induced DNA replication 
stress. PLoS One, 2010. 5(6): p. e11152. 
147. Liu, F.J., A. Barchowsky, and P.L. Opresko, The Werner syndrome protein 
functions in repair of Cr(VI)-induced replication-associated DNA damage. Toxicol 
Sci, 2009. 110(2): p. 307-18. 
148. Cleaver, J.E., et al., Unique DNA repair properties of a xeroderma pigmentosum 
revertant. Mol Cell Biol, 1987. 7(9): p. 3353-7. 
149. Chan, G.L., P.W. Doetsch, and W.A. Haseltine, Cyclobutane pyrimidine dimers 
and (6-4) photoproducts block polymerization by DNA polymerase I. 
Biochemistry, 1985. 24(21): p. 5723-8. 
150. Schultz, R.A., D.P. Barbis, and E.C. Friedberg, Studies on gene transfer and 
reversion to UV resistance in xeroderma pigmentosum cells. Somat Cell Mol 
Genet, 1985. 11(6): p. 617-24. 
151. Phan, A.T. and J.L. Mergny, Human telomeric DNA: G-quadruplex, i-motif and 
Watson-Crick double helix. Nucleic Acids Res, 2002. 30(21): p. 4618-25. 
152. Nagel, Z.D., et al., Multiplexed DNA repair assays for multiple lesions and multiple 
doses via transcription inhibition and transcriptional mutagenesis. Proc Natl Acad 
Sci U S A, 2014. 111(18): p. E1823-32. 
153. Damerla, R.R., et al., Werner syndrome protein suppresses the formation of large 
deletions during the replication of human telomeric sequences. Cell Cycle, 2012. 
11(16): p. 3036-44. 
154. Gillet, L.C., J. Alzeer, and O.D. Scharer, Site-specific incorporation of N-
(deoxyguanosin-8-yl)-2-acetylaminofluorene (dG-AAF) into oligonucleotides 
using modified 'ultra-mild' DNA synthesis. Nucleic Acids Res, 2005. 33(6): p. 
1961-9. 
155. Deng, Z., et al., Telomere repeat binding factors TRF1, TRF2, and hRAP1 
modulate replication of Epstein-Barr virus OriP. J Virol, 2003. 77(22): p. 11992-
2001. 
156. Fousteri, M. and L.H. Mullenders, Transcription-coupled nucleotide excision 
repair in mammalian cells: molecular mechanisms and biological effects. Cell 
Res, 2008. 18(1): p. 73-84. 
157. Kitsera, N., et al., Cockayne syndrome: varied requirement of transcription-
coupled nucleotide excision repair for the removal of three structurally different 
adducts from transcribed DNA. PLoS One, 2014. 9(4): p. e94405. 
158. Mu, D. and A. Sancar, Model for XPC-independent transcription-coupled repair of 
pyrimidine dimers in humans. J Biol Chem, 1997. 272(12): p. 7570-3. 
159. Shivji, M.K.K., et al., Dual-Incision Assays for Nucleotide Excision Repair Using 
DNA with a Lesion at a Specific Site. DNA Repair Protocols, 1999. 113(II): p. 20. 
160. Artandi, S.E., et al., Telomere dysfunction promotes non-reciprocal translocations 
and epithelial cancers in mice. Nature, 2000. 406(6796): p. 641-5. 
117 
161. Sorrentino, J.A., H.K. Sanoff, and N.E. Sharpless, Defining the toxicology of 
aging. Trends Mol Med, 2014. 20(7): p. 375-84. 
162. Chen, Y., et al., A shared docking motif in TRF1 and TRF2 used for differential 
recruitment of telomeric proteins. Science, 2008. 319(5866): p. 1092-6. 
163. Su, Y., et al., Multiple DNA binding domains mediate the function of the ERCC1-
XPF protein in nucleotide excision repair. J Biol Chem, 2012. 287(26): p. 21846-
55. 
164. Ahmad, A., et al., Mislocalization of XPF-ERCC1 nuclease contributes to reduced 
DNA repair in XP-F patients. PLoS Genet, 2010. 6(3): p. e1000871. 
165. Opresko, P.L., et al., Telomere-binding protein TRF2 binds to and stimulates the 
Werner and Bloom syndrome helicases. J Biol Chem, 2002. 277(43): p. 41110-9. 
166. Wu, Y., T.R. Mitchell, and X.D. Zhu, Human XPF controls TRF2 and telomere 
length maintenance through distinctive mechanisms. Mech Ageing Dev, 2008. 
129(10): p. 602-10. 
 
